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Nitrosamines comprise a large group of potentially toxic compounds occurring in the 
environment as by-products of various manufacturing, agricultural and natural processes. 
Nitrosamines are produced from reaction of nitrite with a suitable secondary amine in an 
acidic matrix; these acidic conditions can occur in environmental media and in the 
mammalian gastrointestinal (GI) tract. This research focused on the stability, transfer, and 
impacts of the environmentally relevant nitrosamines, N-nitrosodimethylamine (NDMA), 
N-nitrosmorpholine (NMOR), and N-nitrosoatrazine (NNAT) (formed from reaction of 
nitrite with dimethylamine, morpholine, and atrazine), using the chicken egg and embryo 
model systems. Chicken eggs were used to determine nitrosamine transfer between a 
hydrophilic medium (egg white or albumin) and a lipophilic medium (yolk) via a 
biomembrane (vitelline membrane). Results from these studies with unfertilized chicken 
eggs showed that the selected nitrosamines transferred from the egg white to yolk where 
they were relatively stable. NNAT has a relatively higher affinity for the lipophilic yolk 
fraction, which suggests that it may have a greater potential to bioconcentrate than 
NDMA and NMOR. An understanding of the transfer behavior of nitrosamines can be 
used to assess bioavailability and fate, as well as potential environmental and biological 
impacts. An observed decrease in total nitrosamine in the yolk with time may indicate 
denitrosation, releasing nitrous acid, which can decompose to nitrite and nitric oxide 
(NO), an important biological messenger during embryonic and fetal development. Thus 
teratogenicity of these compounds was assessed using chicken embryos. Major defects 
observed after exposure to these selected compounds included ectopic heart, 
gastroschisis, caudal regression, craniofacial hypoplasia, and neural tube defects. A 
significant relationship was observed between malformed embryos and NNAT (0.46 µg). 
Additionally nitrotyrosine concentrations (a marker of NO-mediated stress) in NNAT 
treated, malformed embryos were greater than those observed in treated, normal-
appearing embryos. Results indicate that NNAT may be teratogenic and that 
nitrotyrosine, a marker of NO-dependent oxidative stress, maybe reflective of one 
biochemical pathway through which nitrosamines exert teratogenic effects.  
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 INTRODUCTION 
          Nitrosamines comprise a large class of mutagenic, teratogenic and carcinogenic 
chemicals found in the environment as by-products of various manufacturing, agricultural 
and natural processes (Magee and Barnes 1967, Lijinksy and Epstein 1970, Loeppky et 
al. 1994, McKnight et al.1999). Nitrosamines generally affect the GI tract, associated 
organs, and the brain (Mirvish 1995). Exposure to nitrosamines is estimated to be 
approximately 1.10 µmol/day (Tricker 1997, Lijinksy 1999). Nitrosamines are found in 
certain foods that contain nitrite or are exposed to nitrogen oxides (Walker 1990). 
Humans are also exposed to a wide range of nitrogen-containing compounds and 
nitrosating agents which can react in vivo under the acidic conditions of the gastric 
environment to form nitrosamines (Mirvish 1975, 1977, Lijinsky and Taylor 1977). N-
nitroso compounds (NOCs) formed endogenously in the maternal stomach may be 
transmitted via the placenta to the fetus (Cowdin et al. 2003). Studies demonstrate that 
exposure to NOCs may be associated with birth defects such as neural tube defects and 
cleft palate, neonatal deaths and stillborns in rodents but the mechanisms are not yet 
understood (WHO, Takeuchi 1984, Carozza et al. 1995).  
          Partitioning between liquid and solid phases, membrane penetration, entry in the 
organs of the host, and subsequent biochemical effects determine chemical toxicity. The 
transfer behavior of nitrosamines can be studied using model systems such as the chicken 
egg. Aside from its use as a model of embryological development, chicken eggs can be 
used to study the partitioning of nitrosamines between hydrophilic or lipophilic biological 
compartments or phases.  
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          The fertilized chicken egg and the developing embryo are useful models for the 
study of teratogenicity. The chick embryo provides an acceptable measure of 
embryotoxic potency (Jelinek et al. 1985) and chicken embryos are widely used to study 
development and developmental abnormalities (Rosenquist et al. 2001, 2007, 2010, Lie et 
al. 2010). 
Denitrosation of nitrosamines in the endoplasmic reticulum may be a pathway of 
detoxification (Lee 1996, Williams 2004) that can lead to increases in nitric oxide which 
can cause cell injury. Hiramoto (2002) demonstrated that nitrosamines decomposed on 
contact with reactive oxygen species, accompanied by release of NO. Nitrotyrosine is a 
product of tyrosine nitration mediated by reactive nitrogen species such as peroxynitrite 
anion and nitrogen dioxide. Its concentration is a marker of NO-dependent oxidative 
stress and may reflect one pathway by which nitrosamines exert their teratogenic effects. 
          The three nitrosamines explored in this thesis are N-nitrosodimethylamine 
(NDMA), N-nitrosomorpholine (NMOR) and N-nitrosoatrazine (NNAT), representing 
environmentally significant nitrosamines. NDMA is a known hepatotoxin and carcinogen 
(Lijinsky et al. 1972, IARC). NMOR has also been found to be carcinogenic in many 
animal species (Preussmann and Tricker 1991, WHO). NNAT can be formed from 
atrazine, a widely used triazine herbicide that has been detected in groundwater (Spalding 
2003).  
          The unfertilized chicken egg and developing embryo were used to determine:  
(1) stability and transfer of the selected nitrosamines among biological compartments,  
(2) teratogenic potential, and (3) impacts on nitrotyrosine concentrations.  
3 
 
LITERATURE REVIEW 
Nitrosamine Formation 
          N-Nitroso compounds (NOC) consist of nitrosamines [RN(NO)R`] and 
nitrosamides [RN(NO)COR`]. N-Nitrosamines comprise cyclic nitrosamines (e.g., 
NMOR) and dialkylnitrosamines (e.g., NDMA) (Magee and Barnes 1967, Mirvish 1977). 
Nitrosamines first drew attention after an outbreak of acute hepatotoxicity in Norwegian 
sheep, which was linked to the presence of NDMA in nitrite-preserved fish meal (Magee 
and Barnes 1967). Magee and Barnes (1967) were the first to discover that NDMA was 
acutely hepatotoxic in a number of animal species. In murine models, nitrosamines have 
been found to induce tumors of the esophagus, nose, liver, kidneys, pancreas and other 
organs (Mirvish 1977).  
          Nitrosamines have been found in foods that contain nitrite or are exposed to 
nitrogen oxides. These foods include fish, alcoholic beverages and cured meats (Walker 
1990), especially bacon in which concentrations of 10-100 µmol/kg have been found 
(Lijinksy 1999). Cooking method, temperature and time influences the formation of 
nitrosamines in meat products (Lee et al. 2003). Humans are also exposed to a range of 
nitrogen-containing compounds and nitrosating agents which can react in vivo to form 
nitrosamines. Nitrosamines may originate from the reaction of nitrite and nitrosatable 
molecules under the acidic conditions of the gastric environment (Mirvish 1975, 1977, 
Lijinsky and Taylor 1977).  
          Mean nitrite levels were 0.1-2.6 and 26-54 µM for fasting gastric juice of pH < 5 
and > 5, respectively (Xu and Reed 1993). An anion transport mechanism actively 
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secretes 25% of the absorbed nitrate into the saliva. Oral bacteria reduce 5% of the 
ingested nitrate to nitrite (Spiegelhalder et al. 1976, McKnight et al. 1999). While nitrite 
itself can be sufficiently toxic, it also serves as a nitrosating agent (Spiegelhalder et al. 
1976, Tenovuo.1986). The reduction of ingested or endogenous nitrate accounts for 
almost 80% of gastric nitrite in the normal acidic stomach. The remaining 20% of gastric 
nitrite arises from ingested nitrite found in processed foods (Mirvish 1977, 1983).  
          Nitrosatable molecules include secondary amines, tertiary amines, alkylureas and 
amino acids (Mirvish 1970, Lijinsky et al. 1972). Under the acidic conditions of the 
human stomach, nitrite is protonated to nitrous acid (HNO2). HNO2 can then 
spontaneously form dinitrogen trioxide (N2O3), nitric oxide (NO), and nitrogen dioxide 
(NO2). NO
+
 can also be donated by N2O3 to secondary and tertiary amines that can then 
form potentially carcinogenic nitrosamines in vivo (Leaf et al.1989). Under neutral 
conditions, NO can be formed from bacterial reduction of nitrite. NO in turn can react 
with molecular oxygen to form the nitrosating agents N2O3 and N2O4. Inducible nitric 
oxide synthase (iNOS) activity of inflammatory cells is also a source of NO. All of these 
mechanisms of endogenous nitrosation account for almost 40-75% of the total human 
exposure to nitrosatable compounds. 
          Secondary amines can be nitrosated to produce a nitrosamine. The formation of 
nitrosamines from secondary amines can be described by the following reactions (Eq. 1-
3): 
N OO H+Na+ Cl- N OOH Na+ Cl-
Sodium nitrite Nitrous acid  
(1) 
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N OOH H+ N OOH
H
H2O N O N O
Nitrous acid Protonated nitrous acid Nitrosonium ion
R N
H
R
N O R N+
R
H
N O
H2O
R N
R
N O H3O
+
Secondary amine Nitrosonium ion Secondary N-nitrosoamine  
The kinetics of the nitrosation reaction depends on the pH of the medium and the 
pKa of the amine. Formation of a nitrosating agent is regulated by pH. The nitrite ion is 
protonated to form HNO2 (pKa 3.37) (Eq. 1). This reaction is favored under acidic 
conditions (which occur in the human stomach). Under these conditions, HNO2 may 
protonate, lose water, and be converted to N2O3 or form other activating nitrosating 
species, including the nitrosonium ion, nitrosyl thiocyanate, or nitrosyl halide (Eq. 2).  
Secondary amines will react with the nitrosonium ion to form nitrosamines (Eq. 3). The 
mechanism for nitrosation involves nucleophilic attack on the nitrosonium ion to form the 
nitrosamine. The unprotonated form of the amine is the more reactive form, so reactivity 
is greater for weak bases (Mirvish 1975, Mergens 1982). Thus, nitrosation occurs readily 
with weakly basic secondary amines such as morpholine and relatively slowly with 
strongly basic secondary amines such as dimethylamine (DMA). The rate of the reaction 
depends on the concentrations of the non-ionized amine and HNO2. At pH > 1, the 
principal nitrosating agent is N2O3. The rate of the reaction is proportional to the 
concentration of nitrous anhydride and the square of nitrous acid, thus the rate of the 
reaction increases tenfold for each one unit decrease in pH (Mirvish 1970, 1972). 
(2) 
(3) 
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          Under suitable conditions, primary amines may be alkylated to form secondary 
amines which can then be nitrosated. Likewise, tertiary amines can be dealkylated to 
form secondary amines which can be nitrosated to form nitrosamines. Tertiary amines 
with dimethylamine functional groups have been identified as potent NDMA precursors 
(Shafer et al. 2010). 
          Nitrosamines can also be formed in an alkaline solution when the nitrosating agent 
is present as N2O3 or N2O4 gas (Challis et al. 1978). The mechanism by which this occurs 
is still not understood completely; however a study (Challis et al. 1978) shows that only 
the unprotonated amino-nitrogen of the selected compounds participates in the nitrosation 
reactions. The possible reaction which may be occurring can be described as follows (Eq. 
4):  
HNO3 + HNO2               ON-NO3                       ON-NO3                 R2NNO + HNO3 
                                                                     R2NH 
                                                                    
          Nitrosamine formation also can occur in the lipid phase, when the reactive amines 
are soluble (Mergens 1982). Unsaturated fatty acids have been shown to enhance (nearly 
double in fatty acid ester solutions) nitrosation of dicyclohexylamine in a lipid medium, 
under aprotic conditions, upon exposure to low concentrations of NO2 (Pryor 1981). The 
nitrosating species under these conditions is HONO formed by the NO2-unsaturated ester 
reactions. Pryor (1981) reported that the rate of nitrosation of the amine nearly doubles in 
the fatty acid solutions. This suggests that the HNO2 (nitrous acid) formed from the 
reaction between NO2 and the unsaturated fatty acid may be participating in nitrosation of 
H2O R2NH 
(4) 2
+
 
Unsymmetrical tautomer 
of N2O4 
Transition  
state 
Secondary  
Nitrosamine 
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the amine. Only the unprotonated (more reactive) amine species would be soluble in a 
lipophilic medium. The pH dependence of the reaction is therefore eliminated and the 
probability of a reaction occurring between an amine and a nitrosating agent is very high 
(Pryor 1981, Mergens 1982).  
          Aside from pH, the rate of nitrosation is influenced by the presence of thiocyanate 
ions, halide ions, and formaldehyde, which accelerate the reaction, and ascorbic acid and 
α-tocopherol that block the formation of N-nitroso compounds (Mirvish 1977). Ascorbic 
acid and α-tocopherol compete for the available nitrite (i.e. N2O3 and H2NO2
+
) and are 
thus capable of inhibiting the formation of nitrosamines. Ascorbic acid reacts rapidly 
with nitrite under acidic conditions to reduce HNO2 to NO and is itself oxidized to 
dehydroascorbic acid. α-Tocopherol reduces NO2 to NO in organic solvents and lipids, 
and its emulsions in water reduce nitrite to NO (Mirvish 1986).  
 
Selected Nitrosamines 
          The nitrosamines explored in this study are N-nitrosodimethylamine (NDMA), N-
nitrosomorpholine (NMOR), and N-nitrosoatrazine (NNAT). The physicochemical 
properties of these nitrosamines and their parent compounds are reported in Tables I and 
II, respectively: 
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Table I. Physicochemical properties of selected nitrosamines 
Structure and Name  Properties  
 
 
 
 
 (NDMA) 
 
 
 
 
 
 
 
 
 
  
 
 
N-Nitrosomorpholine 
(NMOR) 
 
 
 
 
 
 
 
 
 
 
N-Nitrosodimethylamine Volatile yellow oily liquid; 
Soluble in water, organic solvents and 
lipids; 
Photosensitive; 
Molecular weight = 74.1;  
Water solubility = 290 mg/mL;  
Yellow crystals;  
Soluble in organic solvents;  
Photosensitive;  
Molecular weight= 116.1;  
Water solubility = >100 mg/mL;  
Density = 1.11 g/cm³;  
Log Kow = -0.43 
 
Density = 1.005 g/cm³;  
Log Kow = -0.57;  
Log Koc = 1.07   
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Structure and Name  Properties  
 
 
N-Nitrosoatrazine 
(NNAT) 
 
  
  
 
 
 
 
  
Photosensitive; 
Molecular weight= 244.1;  
Water solubility= 0.29 mg/mL;  
Density= 1.42 g/cm
3
 
  Table I continued 
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Table II. Physicochemical properties of parent compounds 
Structure and Name   pKa Properties 
 
 
 
 
 Dimethylamine 
      (DMA) 
 
 
 10.7 Colorless compressed liquefied 
gas with pungent odor ; 
Molecular weight= 450.1; 
Water solubility= 3540 mg/mL; 
Density= 0.67 g/cm
3
;  
Log Kow = -0.38  
 
 
    Morpholine 
 
 
 
  
8.7 
 
 
 
 
 
 
 
 
Colorless oily volatile liquid; 
Water solubility- miscible; 
Molecular weight= 87.1;  
Density- 1.01 g/cm
3
;  
Log Kow = -0.86  
 
 
 
       Atrazine 
        
 
 
 1.7 
 
White solid;  
Molecular weight= 215.7; 
Water solubility= 0.033 
mg/mL; Density= 1.187 g/cm
3
;  
Log Kow = 2.34 
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NDMA 
          NDMA is a known hepatotoxin (Lijinsky and Greenblatt 1972, Pegg 1980, Archer 
et al. 1994) and is classified as an IARC (International Agency for Research on Cancer) 
group 2A carcinogen (probably carcinogenic to humans) (IARC 1987, Lijinsky et al. 
1972). NDMA may be present in air due to reactions between dimethylamine (DMA) and 
nitrogen oxides.  
          NDMA is widely used as an industrial solvent (Mirvish 1977). It can be 
synthesized by soil bacteria from various precursor substances, including nitrate, nitrite, 
and amine compounds. NDMA is also an inadvertent by-product of industrial processes, 
such as reaction of alkylamines DMA with nitrogen oxides, nitrous acid, or nitrite salts, 
or transnitrosation via nitro or nitroso compounds. NDMA may thus be present in 
discharges of rubber manufacturing, leather tanning, pesticide manufacturing, food 
processing, meat tinning and dye manufacturing industries (Mitch et al. 2003, Blicharz et 
al. 2005, Vocht et al. 2007). NDMA has also been identified in baby pacifiers, emissions 
from diesel vehicle exhaust and it can be released from industrial sources as a 
contaminant of products such as liquid rocket fuel (Sen et al. 1985, Mitch et al. 2003). 
NDMA has been detected in the air in chemical (0.05-0.5 µg/m
3
) and rubber industries 
(0.07-0.14 µg/m
3
) (Fajen et al. 1979).  
          Dietary sources of NDMA include beer, fish and fish products, dairy products, 
infant formula, cured meats, cereals and vegetables. In fact, NDMA accounts for almost 
86% of the total nitrosamines in salted fish in China (Bulushi et al. 2009). The 
12 
 
contribution of NDMA from food is considered high even though concentrations in most 
food products are relatively low (Fristachi and Rice 2007, Shafer et al. 2010).  
          California’s Department of Public Health (CDPH) has set 10 ng/L notification 
levels (advisory levels for chemicals in drinking water that lack maximum contaminant 
levels) for NDMA in drinking water. Most nitrosamine releases from industries are to 
sewage and subsequently water. NDMA concentrations as high as 0.11 mg/L have been 
detected in effluents from manufacturing industries (Mitch et al. 2003). DMA and nitrite 
may enter surface water streams from agricultural runoff. NDMA may also be formed 
during treatment of drinking water. Water treatment plants incorporating a chlorination 
process (e.g., sodium hypochlorite) produce NDMA from precursors (WHO, Fristachi 
and Rice 2007, Asami et al. 2009). High levels of NDMA have been detected in outdoor 
and indoor pools and hot tubs (Walse and Mitch 2008). Free chlorine (HOCl) may react 
with ammonia to form monochloramine (NH2Cl) which in turn may react with DMA to 
form dimethylhydrazine ((CH3)2NNH2) which then oxidizes to NDMA (Eq 5-7) (Mitch et 
al. 2003).  
NH3 + HOCl → NH2Cl (MC) + H2O                                                                          (5) 
NH2Cl + (CH3)2NH → (CH3)2NNH2 + H
+
 + Cl
-
                                  (6) 
(CH3)2NNH2 + 2NH2Cl + H2O → (CH3)2NNO + 2NH3 + 2H
+
 + 2Cl
-                               
(7) 
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NMOR 
          NMOR (nitrosated morpholine) is carcinogenic in many animal species (WHO, 
Tricker and Preussmann 1991) and it has been found to be mutagenic (Manson et al. 
1978). NMOR is an IARC group 2B carcinogen (sufficient evidence of carcinogenesis in 
several experimental animal species) (WHO) as it is responsible for inducing liver, nasal-
cavity, tracheal, oesophagus and stomach tumors in several animal models (Lofberg 
1985).         
          Approximately 25000 metric tonnes of morpholine are produced industrially each 
year (WHO). It is a versatile chemical that is used as an intermediate for rubber 
polymerization accelerators, corrosion inhibitors, synthesis of optical brighteners, crop 
protection agents, dyes and drugs, polishes/waxes and food additives (WHO, Mirvish 
1972, Sen et al 1987, Grosjean 1991, Vocht et al. 2007). Some countries still use 
morpholine in toiletry and cosmetic products, and in several direct and indirect food 
additive applications. Human exposure to morpholine arises from gaseous and aqueous 
emissions and directly from some of its uses. NMOR was produced in mice exposed to 
morpholine and NO2 (Mirvish et al. 1981). NO2 itself is a pollutant formed from 
combustion processes such as gas cooking, cigarette smoking, automobile exhaust, and 
flame drying of foods (Cooney and Ross 1987). Morpholine emissions mainly result from 
its manufacture and use in the chemical industry.  Morpholine has been detected in a 
wide variety of foods and tobacco with the source being the coatings of wax on fruit or 
on packaging papers (WHO, Sen 1986). 90-4830 µg/kg of morpholine was detected in 
the waxed cardboard containers used to package snuff and snuff tobacco itself was found 
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to contain NMOR (10-690 µg/kg) (Brunnemann et al. 1982). NMOR levels of up to 140-
670 µg/kg have been detected in waxes used to protect apples (Tricker et al. 1989).   
          Like NDMA, NMOR has been identified as an air pollutant in chemical (0.07 
µg/m
3
-5.1 µg/m
3
) and aircraft tire industries (0.6 µg/m
3
- 27 µg/m
3
) (Fajen et al. 1979, 
Spiegelhalder and Preussmann 1983). NMOR has been detected in the rubber industry 
and in diesel engine crankcase emissions (Lofberg 1985). Disinfected wastewater 
effluents have also been shown to contain NMOR (Kulshrestha et al. 2010). NMOR has 
been identified in drinking water at maximum concentrations of about 3 ng/L (Padhye 
2010). 
 
NNAT 
          NNAT (nitrosated atrazine) can be formed from atrazine, a widely used broadleaf 
triazine herbicide that has been detected in groundwater (Spalding et al. 2003). Exposure 
to atrazine may occur on the application of the herbicide or consumption of contaminated 
food or water (Mirvish et al. 1991). Due to the widespread application of agrichemicals in 
the Midwest, some groundwaters are contaminated with nitrate and atrazine. 
Groundwater contaminated with atrazine often contains nitrate. A 1997 study (Gosselin et 
al. 1997) reported detection of atrazine in 70 Nebraska domestic wells. Wells 
contaminated by atrazine had a median nitrate-nitrogen concentration of 11.5 µg/L. High 
concentrations of atrazine (1500 µg/kg) have been detected in Wisconsin, where the wells 
also have high nitrate levels (Meisner et al. 1993). Elevated concentrations of nitrate and 
atrazine create the potential for NNAT formation after ingestion. Thus exposure to 
atrazine and nitrate may occur via consumption of contaminated water.  Atrazine is a 
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secondary amine that can be readily nitrosated to form nitrosoatrazine under suitable 
conditions (Mirvish et al. 1991). Atrazine nitrosates almost 200 times faster than DMA at 
pH 2 (Wolfe et al. 1976) and NNAT is relatively stable at alkaline pH (Mirvish et al. 
1991). NNAT is more photolabile than NMOR in water or CH2Cl2 which may be due to 
UV absorption by its triazine ring (Wolfe et al. 1976, Mirvish et al. 1991). NNAT is also 
mildly mutagenic in the Ames assay (Weisenburger et al. 1988, Gammon et al. 2005). 
Meisner (1993) found that exposure of lymphocytes to NNAT resulted in chromosome 
breakage.   
Nitrosamine Sources and Exposure 
          Nitrosamines have been studied extensively in foods as they are found in certain 
foods that contain nitrite or are exposed to nitrogen oxides. These foods include dried 
salted fish, alcoholic beverages and cured meats (Mirvish 1977, Walker 1990), especially 
bacon in which concentrations of 10-100 µg/kg have been found (Lijinksy 1999). Human 
exposure to nitrosamines is estimated to be approximately 1.10 µmol/d. Major sources of 
exposure are the diet (0.79 µmol/d, 80-120 µg/d; 72% of the total exposure), occupational 
exposure (0.15-0.30 µmol/d; 25%), cigarette smoking (0.02 µmol/d, 3.4 µg /d; 2%), and 
miscellaneous sources, including pharmaceutical products (Brambilla et al. 1985, 
Dawson and Lawrence 1987), cosmetics, indoor and outdoor air (0.001 µmol/d, 0.1 µg/d; 
1%) (Tricker 1997). Consumer products such as foods, beverages, pharmaceutical drugs 
and cosmetics that contain nitrosatable compounds and nitrite or have been exposed to 
nitrous oxides can be a source of nitrosamines (Rosenberg et al. 1980, Tenovuo 1986, 
Lijinksky 1999, Yurchenko and Molder 2006).            
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          While nitrate levels are highest in vegetable products (189 mg of nitrate/serving), 
nitrite levels are highest in meat and bean products (1.84 mg/serving). Alcohol, meat and 
dairy products contain the highest concentrations of nitrosamines (0.531 µg/serving) 
(Griesenbeck et al. 2009) (serving indicates standard serving sizes in the United States as 
reported by the Centers for Disease Control).  
          While there is considerable research on nitrosamine exposure from food, concern 
has been expressed about nitrosamine formation, occurrence and exposure in the 
environment. A number of drugs are secondary or tertiary amines (e.g. chlorpheneramine, 
cefadroxil, diphenhydramine, ethambutol, furosemide, metoprolol, procainamide, 
propranolol, and ranitidine) and can be easily nitrosated to form NOC. Large doses of 
drugs are ingested by mouth and their chronic presence in the GI tract could be hazardous 
if they nitrosate to form carcinogenic NOCs. For example, oxytetracycline reacts 
endogenously with nitrite to form NDMA. Similarly, methapyrilene and 
chlorpheniramine can also react with nitrite to form NDMA (Mirvish 1995). 
          Occupational exposure to volatile nitrosamines occurs in rubber/latex and leather 
curing industries. NDMA and NMOR have been detected in the air of rubber industries. 
These are thought to arise from the reaction of exhaust NO2 with amines arising from 
vulcanization accelerators (Mirvish 1995). Average daily intake of NDMA by individuals 
working in rubber industries is 0.8 µg/m
3 
(Tricker et al. 1989). The estimated daily intake 
of NMOR by individuals working in rubber industries is 3.8 µg
 
(Tricker 1989).  
          Of the three nitrosamines considered for this study, the presence of and exposure 
from NDMA has been examined most extensively. NDMA concentrations as high as 70 
µg/L have been detected in German beer, although levels are usually much lower (5-10 
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µg/L). In the U.S., the estimated dietary exposure to NDMA from beer is almost 0.3-0.97 
μg/d (Walker 1990). NDMA has also been detected in bacon (17 µg/kg), smoked pickled 
fish (32 µg/kg) and Japanese broiled squid (300 µg/kg) (Lijinksky 1999). NDMA has 
been identified in Korean dried seafood products and cooking has been shown to increase 
the NDMA content (from about 147 to 630.5 µg/kg) (Lee et al. 2003). NDMA 
concentrations of 0.003-0.4 mg/L have been found in groundwater near rocket engine 
testing facilities (Mitch et al. 2003). High concentrations of nitrosamines have been 
detected in latex gloves and studies have shown that these can migrate and be potentially 
toxic (Feng et al. 2009). NDMA is still found in some fish products (Mirvish 2008). A 
daily tolerance limit of  4 - 9.3 ng NDMA/kg/d or 280– 650 ng/d for a 70 kg person has 
been identified (Schafer et al. 2010).  
 
Nitrosamine Carcinogenicity and Mutagenicity 
          In animal models, nitrosamines induce tumors of the liver, nose, kidneys, pancreas, 
esophagus and other organs. Several studies have shown that tumors are induced in mice 
after treatment with sodium nitrite together with various secondary amines (Mirvish 
1972). More than 300 NOCs are carcinogenic in one or more animal species (Preussmann 
and Stewart 1984, Hasegawa et al. 1998). Exposure to nitrosamines has been associated 
with mortality from cancers of the oesophagus, oral cavity, and pharynx (Straif et al. 
2000). NNAT was also mutagenic in the Ames assay (Weisenburger et al. 1988, 
Gammon et al. 2005).  
          Nitrosamines require metabolic activation to exert carcinogenic and mutagenic 
effects. Cytochrome P450 (P450) enzymes activate nitrosamines in the endoplasmic 
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reticulum to form α-hydroxynitrosamines, which spontaneously decompose to form 
monoalkylnitrosamines and alkyldiazohydroxides (Magee and Barnes 1967, Mirvish 
1977, 1995). Formation of monoalkylnitrosamines followed by alkyldiazohydroxides is 
known as dealkylation. Alkyldiazohydroxides are capable of alkylating nucleophiles to 
form diazoalkanes, some of which can alkylate DNA bases especially at N-7 and O-6 of 
guanine and O-4 of thymine (Mirvish 1995). This induces mutations which are thought to 
initiate carcinogenesis. DNA damage due to alkylation of N-7 in guanine also generates 
reactive oxygen species such as superoxide (O2
-
) and hydrogen peroxide (H2O2). 
Consequences include increased lipid peroxidation, protein adduct formation, and pro-
inflammatory cytokine activation (Tong et al. 2010). 
 
Teratogenic Potential of Nitrates, Nitrites and Nitrosamines 
          Maternal exposure to nitrosatable compounds may be related to birth defects 
(WHO, Takeuchi 1984, Carozza et al. 1995, Croen et al. 2001, Cowdin et al. 2003, 
Brender et al. 2004, Manassaram et al. 2007). Associations have been found between 
occupational exposure in agricultural work and pesticides and the risk of anencephaly (a 
neural tube defect that occurs when the cephalic end of the neural tube fails to close, 
resulting in the absence of a major portion of the brain, skull, and scalp) and other 
adverse pregnancy outcomes such as spontaneous abortion and preterm delivery 
(Greenlee et al. 2004, Lacasana et al. 2006).   
          NDMA decreased the hatching of fertilized eggs in carp (Bieniarz et al. 1996). Ten 
mg/kg of methylnitrosourea induced limb and other defects in murine models (Koyama et 
al. 1970, Iannaccone et al. 1982). Exposure to N-methyl-N-nitrosourea also increased 
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gross malformations in mice (Bossert and Iannaccone, 1985) and N-methyl-N’-nitro-N-
nitrosoguanidine induced mid line defects in mice (Inouye and Murakami 1978). NDMA 
is lethal to or inhibits the growth of chick embryos (Maduagwu and Bassir 1979). A 
methyl derivative of NDMA, N-Methyl-N-(α-acetoxy)methyl-nitrosamine is a strong 
teratogen in a mouse limb bud culture system (Stahlmann et al. 1983). Takeuchi (1984) 
showed that exposure to N-nitroso compounds was associated with neural tube defects 
and cleft palate in mice. Certain nitrosatable drugs have been associated with an 
increased risk of craniosynostosis (premature fusion of the sutures of the skull). It has 
been suggested that ischaemia (restriction in blood supply) and reperfusion injury (tissue 
damage caused after a period of ischemia) leading to an increase in the rate of formation 
of NO may be the cause of dysmorphogenesis (Gardner et al. 1998). 
          A 2004 epidemiological study reported an association between intake of dietary 
nitrite and neural tube defects in humans (Brender et al. 2004). Croen showed that 
maternal exposure to nitrate-contaminated drinking water was associated with risk of 
neural tube defects (Croen et al. 2001). Exposure to nitrate in drinking water at levels 
greater than 45 mg/L (the maximum contaminant level) and in groundwater at 
concentrations below the maximum contaminant level has been associated with an 
increased risk for anencephaly (Croen 2001). Many other studies have indicated links 
between drinking water containing nitrate and neural tube defects (NTDs) (Ward et al. 
2005). The risk of NTDs from high levels of nitrates in food/water increases if mothers 
are exposed to nitrosatable drugs (Brender et al. 2004, Manassaram 2007).  
         Elevated concentrations of dietary nitrosamines have been significantly 
associated with gastroschisis (failure of the abdominal wall to close) (Torfs et al. 1998). 
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In fact, several studies have shown an increase in the rates of gastroschisis and other 
abdominal wall defects in the past two decades (Laughon et al. 2003, Alvarez et al. 2007, 
Collins et al. 2007, Vu et al. 2008). Annola et al. (2009) demonstrated that the human 
fetus can be exposed to NDMA from maternal blood circulation. 
 
Nitrosamine Dealkylation and Denitrosation 
          Research is limited regarding the denitrosation of nitrosamines and fate in 
environmental media and in the mammalian digestive tract. Nitrosamines can be reduced 
across the N-N bond or the N-O bond. Reduction across the N-N bond releases the parent 
amine and nitrous acid. The nitrous acid released can decompose to nitrogen dioxide, 
nitric oxide and water. It may also decompose to nitric acid, nitrous oxide and water (Eq. 
8). Near the site of NO production, NO reacts with dissolved oxygen to form N2O3 and 
N2O4 which react with water at neutral pH to form nitrite and nitrate, and with amines to 
form nitrosamines (Mirvish 1995). Reduction across the N-O bond yields a hydrazine 
which can be further reduced to the parent amine and ammonia (Eq. 9). Hydrazine 
formation may be a pathway for bioactivation as it is a highly reactive base and reducing 
agent.  
                
O
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          Metabolism of nitrosamines includes dealkylation and denitrosation. Denitrosation 
in the endoplasmic reticulum may be a pathway of detoxification (Lee 1996, Williams 
2004). There are two denitrosation mechanisms mediated by P450 isoenzymes. One 
electron reduction produces NO and the secondary amine which may be dealkylated. One 
electron abstraction liberates NO via an oxidative mechanism involving the formation of 
an aminium cation radical. An alkylidenaminoalkane is formed due to the loss of a proton 
which in turn hydrolyses to the primary amine and the corresponding aldehyde 
(Haussmann and Werringloer 1987, Appel et al. 1991). Studies with rat liver microsomes 
have demonstrated that denitrosation of NDMA accounts for the formation of 
methylamine and the production of NO via an oxidative mechanism, which is a precursor 
of nitrite (Keefer et al. 1987, Haussmann 1987). Although denitrosation is a possible 
mechanism of detoxification of the nitrosamine, toxic effects due to NO and its 
conversion to nitrite and nitrate (due to intermediate formation of the NO2 radical) are 
possible (Appel et al. 1991).  
          Denitrosation can increase NO and can lead to cell injury (Lee 1996, Williams 
2004). The liberated NO also may result in formation of nitrosamines via nitrosation. 
Hiramoto (2002) demonstrated that on contact with reactive oxygen species (ROS), N-
nitrosamines decomposed, with release of NO. Nitrosamine metabolism may result in the 
formation of ROS, including hydrogen peroxide (H2O2), superoxide anion (O2
-
), and 
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hydroxyl radicals (OH
•
). These ROS may cause oxidative stress and possible induction of 
hepatocellular necrosis, carcinogenesis, tumor formation and other cell damage (Farombi 
et al. 2009).  
 
Nitric oxide, Peroxynitrite and Nitrotyrosine 
          Nitric oxide (NO) is an important biological messenger that mediates critical 
physiological processes, including gene regulation, immune regulation, apoptosis, 
neurotransmission and vascular smooth muscle cell relaxation (Stamler et al. 1992, 
Tiboni and Clementini 2004). NO synthesis via oxidation of L-arginine involves unusual 
chemistry that has uncovered novel aspects of eukaryotic enzymology. L-arginine 
synthesizes NO by the enzyme nitric oxide synthase (NOS) (Stamler et al. 1992, Tiboni 
and Clementini 2004). Of the three isoforms of NOS, the constitutive isoforms nNOS 
(neuronal NOS) and eNOS (endothelial NOS) produce small amounts of NO while iNOS 
(inducible NOS) produces much larger amounts of NO (Dijkstra et al. 1998). The 
biological activity of NO is due to its direct actions on the enzyme guanylyl cyclase. The 
activation of guanylyl cyclase by low concentrations of NO is the major pathway of NO 
signaling that is involved in the regulation of many physiological functions such as 
neurotransmission and vascular smooth muscle relaxation (Moncada et al. 1991).  
          Studies show that a change in NO can alter NO
-
 mediated intracellular signaling 
which can adversely affect embryonic and fetal development (Fantel and Person 2002, 
Trapp et al. 2006). Excessive or inadequate NO can lead to reproductive and 
developmental failure (Tiboni and Clementini 2004). Inhibition of NO may lead to limb 
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defects (Tiboni and Clementini 2004). Abnormally high levels of NO are involved in the 
hypotension associated with endotoxic shock (Kilbourn and Belloni 1990) and 
inflammatory response-induced tissue injury (Mulligan et al. 1991). A recent study by 
Alexander et al. (2007) demonstrated that changes in NO levels resulted in morphological 
defects of the heart, neural tube and eyes in chick embryos. While NO itself can be 
cytotoxic, it may also exert adverse effects via production of other oxidizing agents 
(Dijkstra et al. 1998).          
          Peroxynitrite (ONOO
-
) is produced by the reaction of NO with superoxide radical 
(O2
•
) which occurs at a high rate (Kaur 1994). Peroxynitrite is a potent oxidizing agent 
that has been implicated in various pathological conditions. The adverse effects of 
ONOO
- 
include tissue damage by lipid peroxidation and DNA strand breaks leading to 
apoptosis and oxidation of protein sulfydryl groups (Dijkstra et al. 1998). The half-life of 
ONOO
-
 in vivo is quite short which is why it is usually measured in terms of the 
formation of the comparatively more stable nitrotyrosine (Takizawa et al. 1999). 
Peroxynitrite can decompose to products that nitrate aromatic amino acids, which can be 
markers of NO
-
 dependent oxidative damage in vivo (Kaur 1994). One of these markers is 
3-nitrotyrosine. Measuring 3-nitrotyrosine may be a useful way to provide evidence of 
NO
-
 mediated pathology as it is indicative of a more intense oxidative stress (Kaur 1994, 
Pacher et al. 2007). 
          Nitrotyrosine is produced when ONOO
- 
reacts with tyrosine (i.e. it induces 
nitration of tyrosine) or to proteins containing tyrosine residues (Halliwell et al. 1997, 
Gal et al. 1997). Tyrosine nitration involves addition of a –NO2 group near the –OH 
group on the tyrosine aromatic ring. For tyrosine nitration to occur, a hydrogen atom is 
24 
 
abstracted from tyrosine to form a tyrosyl radical. The tyrosyl radical then rapidly reacts 
with nitrogen dioxide to form 3-nitrotyrosine (Pacher et al. 2007). This nitration of 
tyrosine residues can subsequently result in the loss of protein structure, function and 
activity, which may compromise cell signal transduction, alter cytoskeletal organization 
and bring about a change in the catalytic activity of enzymes. This is why tyrosine 
nitration is considered a vital aspect of peroxynitrite-mediated cytotoxicity (Pacher et al. 
2007).  
          Nitrotyrosine levels are elevated in many pathological conditions where 
inflammation is observed. Nitrotyrosine is also elevated in the plasma protein of people 
with chronic renal failure, atheroschelrotic plaque, and ischemia-reperfusion injury. High 
nitrotyrosine levels are also observed in people with diseases that have a high oxidative 
stress burden such as diabetes (Takizawa et al. 1999, Nakazawa et al. 2000, Mohiuddin et 
al. 2006). Elevated nitrotyrosine concentrations have been found in malformed murine 
embryos (Trapp et al. 2006).   
 
Use of chicken egg and embryo model systems to assess bioavailability and potential 
teratogenicity 
          Health risks do not always correlate with the total amount of toxicant in an 
environmental matrix or a biological system. While all of the nitrosamine that is present 
may be considered bioaccessible, assessment of potential impacts requires a 
determination of bioavailability. Bioavailability is the rate and extent to which an active 
agent is absorbed and becomes available at the site of action. The bioaccessible fraction 
25 
 
is considered to represent the maximum amount of contaminant that is available for 
intestinal absorption. Bioaccessible fractions of nitrosamines may be absorbed and 
transferred into the blood (or lymph) stream (Oomen et al. 2002) and bioavailability 
depends, in part, on the route of exposure (Caussy 2003, Harmsen 2007).  
          Partitioning between liquid and solid phases, membrane penetration, entry in the 
organs of the host, and subsequent biochemical effects determine nitrosamine toxicity. 
The partitioning behavior of nitrosamines can be studied using model systems. Aside 
from serving as a model of embryological development, chicken eggs can be used to 
study the transfer of nitrosamines among biological compartments.  
          In chicken eggs, the yolk is centered in the albumin or egg white and is surrounded 
by the vitelline membrane (Fig.1). The egg white (pH 7.9-8.0) makes up 60% of the total 
egg weight and is comprised of the proteins ovomucin, globulins, conalbumin, 
ovalbumin, lysozyme, ovotransferrin and ovomucoid (Palmer 1944, Mine 2007). Water is 
the major constituent of egg white (88%) while proteins account for 11%. Polar amino 
acids alternate along the peptide chain in egg white. Egg yolk contains nonpolar 
triacylglycerols and polar phospholipids. In the yolk (pH 5.9-6.0), polyedric droplets are 
surrounded by a membrane in which high density lipoprotein granules and low density 
lipoprotein micelles are held in the aqueous phase. Egg yolk lipids include cholesterol, 
triglycerides, cerebrosides and phospholipids (Palmer 1944, Mine 2007). The vitelline 
membrane is composed of glycoprotein, carbohydrate and lipids (Ternes 2001). Thus the 
egg serves as an ideal model to study the transfer of the selected nitrosamines between 
the hydrophilic and lipophilic phases. 
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Fig.1. Structure and components of the chicken egg. 
The embryotoxic potential of a compound depends on factors such as dose, critical 
window of exposure and sensitivity of the developing morphogenetic system at the time 
of administration. Also important is the metabolic activity of the morphogenetic system 
that transforms a substance to active or inactive metabolites.  
          The chicken egg and developing embryo are useful models for the study of 
teratogenicity. Chicken embryos are widely used to study development and 
developmental abnormalities (Rosenquist et al. 2001, 2007, 2010, Lie et al. 2010). The 
chick embryo in ovo represents a morphogenetic system that includes epigenetic tissue 
interactions and it possesses a drug metabolizing capacity. The chick embryo provides an 
acceptable measure of embryotoxic potency (Jelinek et al. 1985). It is an inexpensive and 
rapid in vitro model system. Hamburger and Hamilton staged the chicken embryo in 
1951, describing the various features of the chicken that can be observed at specific times 
(mean of a range) after fertilization.  The chicken embryo reaches the blastoderm stage 
by the time the egg is laid.  Three h after fertilization the newly formed single cell divides 
and division continues until there are many cells grouped in a small, whitish spot visible 
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on the upper surface of the egg yolk. Within the first 24 h, the alimentary tract appears 
and the brain crease, nervous system and head fold begin to form. The heart starts to beat 
within 48 h (Hamburger and Hamilton 1951). The external form of chicken embryos at 
various stages of development can be studied beginning with the second or third day of 
incubation by carefully breaking open or windowing an egg each day (Matthew et al. 
2007). Defects such as neural tube abnormalities can also be detected by observing the 
developing embryo within 36 h of incubation (Madeleine et al. 2005). Thus the chick 
embryo model can provide a useful tool to screen for toxicity and developmental 
abnormalities.  
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MATERIALS AND METHODS 
Chemical Reagents and Eggs 
          All chemicals used in the experiments were analytical grade. Atrazine (98%) was 
obtained from Chem Service (West Chester, PA). NDMA and NMOR were purchased 
from Sigma-Aldrich (St. Louis, MO). NNAT was synthesized using the method of 
Mirvish et al. (1991). Fertilized chicken eggs were obtained from Charles River 
Laboratories International, Inc (Wilmington, MA).  
 
Nitrosamine Stability and Transfer among Biological Compartments 
          Unfertilized chicken eggs were used to characterize the stability and transfer of the 
selected nitrosamines.  To determine the stability of NDMA, NMOR and NNAT, the egg 
white, membrane and yolk were separated and weighed. One mL of deionized, distilled 
(DD) water containing 1 mg nitrosamine/mL was added to individual fractions of the egg. 
After incubation on a rotary shaker at room temperature (ca. 25 °C) for different time 
intervals (4, 6, 10, 16 and 24 h), the yolk, egg white and membrane fractions were 
separated and weighed. Using methodology similar to the EPA SW846 method for 
nitroaromatics and nitramines, nitrosamines were extracted from each egg fraction. In 
this procedure, acetonitrile was added to each fraction and the samples were placed on 
the shaker for 16 h. The supernatant was centrifuged, filtered and analyzed by HPLC 
(Shimadzu, Kyoto, Japan), using a 250 × 4.6 mm Keystone NA column (Thermo 
Hypersil-Keystone, Bellefonte, PA).  
    To characterize the transfer of the selected nitrosamines between the biological 
compartments, NDMA, NMOR and NNAT were added to the air cell, via a window, and 
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the treated eggs were placed on a rotary shaker at room temperature for varying time 
intervals (1, 4, 6, 10, 16, 24, 48, 72 and 120 h). After incubation and subsequent 
separation of the fractions, the same method of extraction, detection and quantification 
was used to determine the amount of nitrosamine in each fraction of the egg.  
    To determine nitrosamine transfer within the egg, its distribution between just two 
fractions was studied. To determine the distribution between the egg white and 
membrane, the yolk was removed and the nitrosamine was added to the egg white-
membrane matrix. For the distribution between membrane and yolk, the egg white was 
removed after which the nitrosamine was added. To determine the distribution between 
egg white and yolk, the nitrosamine was added to the egg. Treated eggs were placed on a 
rotary shaker at room temperature for varying time intervals (1, 4, 10 and 24 h), after 
which the amount in each fraction was determined. Extraction and analysis of the 
nitrosamine were carried out using the method described above. All values were 
corrected for recovery. 
 
Teratogenic Potential 
          Experiments were performed using a chick embryo model to determine dose-
response and evaluate the teratogenic potential of atrazine, NDMA, NMOR and NNAT. 
Pathogen-free fertilized chicken eggs were incubated in a forced air incubator at 38 °C 
and 65–75% relative humidity for 30 h (HH stage 9 – 10; Hamburger and Hamilton 
1951). The eggs were treated in the air cell at HH stage 9 -10, when there are 7 to 10 
somites (Hamburger and Hamilton 1951), by delivering 50 µL of DD water containing 
various concentrations of each of the selected nitrosamines using a micropipette. 
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Negative controls included fertilized eggs injected with DD water. The eggs were 
returned to the incubator after dosing. The embryos were harvested at days 3 (72 h, HH 
stage 20) and 5 (120 h, HH stage 27) and examined microscopically for soft tissue and 
skeletal abnormalities, including: neural tube defects (failure of the neural tube to close), 
craniofacial hypoplasia (tissue deficiency or agenesis, failure of an organ to develop 
during embryo development), microphthalmia (abnormally small eye/s), anophthalmia 
(absence of one or both eyes), ectopic heart (displacement of the heart outside the 
thoracic cavity), gastroschisis (intestines and other organs develop outside the fetal 
abdomenfailure of the abdominal wall to close), and caudal regression (lack of or the 
degenerative regression of the caudal aspect of the embryo leading to absence or lack of 
caudal stuctures). 
          Embryos were compared to the negative controls to identify developmental 
anomalies and assess mortality and abnormality rates. The amounts of nitrosamine in the 
50 µL injections and concentrations of the three nitrosamines used to treat fertilized 
chicken eggs are reported in Table III. 
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Table III. Dose and concentration of selected nitrosamines 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound Dose  
(µg in 50 µL DD 
water) 
Concentration 
(µg/g egg matrix (excluding egg shell)) 
NDMA 
 
12.5 
25.0 
50.0 
 
0.2 
0.5 
0.9  
 
 
 
 
 
 
25.0 
250.0 
1250.0 
2500.0 
5000.0 
7500.0 
 
  0.5  
  4.7 
  23.6  
  47.2 
  94.3 
  141.5 
 
 
            0.06 
           0.01 
           0.2 
           0.5 
           0.9 
  0.001 
 0.002 
 0.004 
  0.009 
  0.017 
NMOR 
NNAT 
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Table III continued  
 
 
 
  1.8  0.03 
                               3.6                                0.07 
                               5.5 0.10 
                               7.3 0.14 
                               14.5                                            0.27 
 
                               16.5                                            0.31 
 
 
 
Nitrotyrosine Determination 
          Measuring the stable 3-nitrotyrosine may be a useful way to provide evidence of 
NO-mediated pathology as it is indicative of intense oxidative stress. Nitrotyrosine was 
measured in tissue sonicates of embryos treated with DD water (negative controls), 
embryos treated with NNAT that appeared normal and embryos treated with NNAT that 
were malformed using the OxisResearch™ Bioxytech® Nitrotyrosine Enzyme 
Immunoassay (EIA) for Nitrotyrosine (Portland, OR). The EIA is a “sandwich” ELISA. 
The antigen that is captured by a solid phase monoclonal antibody is detected with a 
biotin labeled goat polyclonal anti-nitrotyrosine. A streptavidin peroxidase conjugate then 
Compound Dose  
(µg in 50 µL DD 
water) 
Concentration 
(µg/g egg matrix (excluding egg shell)) 
NNAT 
Atrazine 
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binds to the biotinylated antibody. A tetramethylbenzidine (TMB) substrate is added and 
the yellow product is measured at 450 nm. Nitrotyrosine concentrations (expressed in 
terms of nmol/µg Protein) were measured in tissue sonicates of five-day-old embryos 
treated with different doses of NNAT (0.06, 0.23, 0.46, 0.91 and 3.63 µg/50 µL) and 
deionized, distilled water (controls). Protein concentrations (expressed as µg/µL) were 
determined in control and treated embryos using the Bradford assay (Bradford 1976, 
Kruger 2002).   
 
HPLC Analyses  
          The nitrosamines (NDMA, NMOR and NNAT) and atrazine were identified and 
quantified by HPLC. HPLC analyses were carried out by injecting 10 µL of sample onto 
a 250 × 4.6 mm Keystone NA column (Thermo Hypersil-Keystone, Bellefonte, PA). 
HPLC mobile phases and operating conditions for the nitrosamine analyses are given in 
Table IV.  
 
TABLE IV. HPLC conditions for nitrosamine analyses 
Compound Wavelength 
(nm) 
Flow rate 
(mL/min) 
Mobile phase 
NDMA 220 1.0 70:30 Methanol:Water 
NMOR 248 1.0    50:50 Water:Acetonitrile 
NNAT 246 1.0    50:50 Water:Acetonitrile 
Atrazine 235 1.0            50:50 Water:Acetonitrile 
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Statistical Analyses 
Chi square tests (SAS, Cary, NC) were used to examine the relationship between 
NDMA, NMOR and NNAT treatment and the subsequent effect observed (i.e., 
embryo death and malformation). Differences in nitrotyrosine concentrations between 
and within groups (i.e., treated malformed, treated normal and controls) were 
determined by analysis of variance (ANOVA) in SAS (SAS Institute Inc., Cary, NC). 
Risks of mortality and malformations from exposure to the three nitrosamines (versus 
the non-exposed group i.e. controls) were determined by Relative Risk in SAS (SAS 
Institute Inc.). Relative risk is the risk of developing a particular condition (in this 
case malformations and mortality) for one group compared to another group:  
Relative risk =   P exposed / P non-exposed. Analysis of relative risk is used frequently in the 
statistical analysis of binary outcomes where the outcome of interest has relatively 
low probability. For all analyses, statistical significance was accepted at a p value = 
0.05. 
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 RESULTS AND DISCUSSION 
Stability and Transfer of Selected Nitrosamines 
To study the stability and transfer of nitrosamines, experiments were carried out using 
unfertilized chicken eggs. Results indicate that NDMA, NMOR and NNAT partition into 
the yolk where they are fairly stable and it is hypothesized that this may impact NO 
concentrations during embryo development in fertilized eggs. Standard deviations (n=3) 
were typically small for egg white and yolk measurements but large for membrane 
measurements due to the difficulty in separating this fraction.  
 
Stability of NDMA 
To determine the stability of NDMA in the various fractions of the egg, a known amount 
was added to each fraction and the amount remaining was determined over time.  
    The amounts of NDMA in the egg white and yolk were relatively constant over time 
(Fig. 2), indicating that NDMA is quite stable in the egg white and yolk. 
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Fig. 2. NDMA stability in egg white (albumin) (●) and yolk (○) in a 24-h experiment. 
Error bars indicate mean standard deviations; where absent bars fall within symbols. 
 
NDMA Transfer among Egg Fractions 
          NDMA amount and concentration within the egg white decreased during 120 h of 
incubation (Fig. 3). The NDMA content increased in the yolk, while it decreased in the 
membrane from 1 to 24 h and then increased to 72 h after which a decrease was observed 
(Fig. 3).  The decrease in NDMA in the egg white and concomitant increase in the yolk 
with time suggests that NDMA partitions from the egg white into the yolk. 
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Fig. 3. NDMA concentrations (µg/g) in the albumin (egg white), membrane and yolk, 
and total amount of NDMA (mg) in the albumin (egg white) (●), membrane (○) and yolk 
(▼) during 120 h of incubation. Error bars indicate mean standard deviations; where 
absent bars fall within symbols. 
 
    The total amount of NDMA in the egg decreased during 120 h of incubation 
(Table V). This suggests that NDMA gradually decomposes. The NDMA may be 
denitrosating to the parent compound (DMA) and/or is being transformed to other 
products (not determined).  
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TABLE V. Total NDMA in the egg during a 120-h experiment (1 mg added) 
Time  
(h) 
NDMA in Egg     
(mg) 
NDMA Lost or Unaccountable       
(    (mg)                    (%) 
 1 0.70 (0.009)
a
 0.30 30  
 4 0.73 (0.004) 0.27 27  
 6 0.68 (0.003) 0.32 32  
10 0.67 (0.010) 0.33 33  
24 0.66 (0.007) 0.34 34  
48 0.65 (0.009) 0.35 35  
72 0.65 (0.008) 0.34 34  
120 0.60 (0.013) 0.40 40 
    a
 Values in parenthesis indicate standard deviations (n = 3) 
 
Transfer between Fractions 
          On analyzing the distribution of NDMA between two layers, NDMA decreased in 
the egg white with time while the amount in the vitelline membrane increased (Table VI). 
This shows transfer of NDMA from the egg white to the membrane. In the membrane-
yolk matrix, the amount of NDMA in the membrane decreased with time while that in the 
yolk remained constant after an initial increase (Table VII), suggesting transfer from the 
membrane to the yolk. The distribution of NDMA between the egg white and yolk also 
indicated transfer from the egg white into the yolk over a period of time (Table VIII).  
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TABLE VI. NDMA in the membrane and egg white of an egg white-membrane 
matrix during a 24-h experiment (1 mg added) 
 Egg white Membrane Total 
Time  
 
(h) 
Amount  
 
(mg) 
Relative 
percent 
(%) 
Amount 
 
(mg) 
Relative 
percent 
(%) 
Amount  
 
(mg) 
Loss  
 
(%) 
 1 0.33 
(0.004)
a
 
60 0.22 
(0.008) 
40 0.55 45 
 4 0.30 
(0.021) 
52 0.28 
(0.005) 
48 0.58 42 
10 0.16 
(0.001) 
33 0.32 
(0.005) 
67 0.48 52 
24 0.11 
(0.024) 
24 0.35 
(0.003) 
76 0.46 54 
a
 Values in parenthesis indicate standard deviations (n = 3) 
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Table VII. NDMA in the membrane and yolk of a membrane-yolk matrix during a 
24-h experiment 
 Membrane Yolk Total 
Time Amount Relative 
Percent 
Amount Relative 
Percent 
Amount Loss 
(h) (mg) (%) (mg) (%) (mg) (%) 
  1 0.88 
(0.008)
a
 
69 0.39 (0.009) 31 1.27 23 
  4 0.60 
(0.006) 
60 0.40 (0.023) 40 1.00  0 
  6 0.44 
(0.017) 
47 0.49 (0.013) 53 0.93  7 
10 0.39 
(0.019) 
42 0.54 (0.006) 58 0.93  7 
16 0.34 
(0.011) 
43 0.45 (0.010) 57 0.79 21 
24 0.24 
(0.014) 
38 0.40 (0.011) 63 0.64 36 
a
 Values in parenthesis indicate standard deviations (n = 3) 
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Table VIII. NDMA in the egg white, membrane and yolk during a 24-h experiment 
          Egg white         Membrane               Yolk           Total 
Time Amount Relative  
Percent 
Amount Relative  
Percent 
Amount Relative  
Percent 
Amount  
 
Loss 
(h) (mg)  (%)  (mg) (%) (mg) (%) (mg) (%) 
  1 0.42 
(0.009)
a
 
  63 0.16 
(0.019) 
  23  0.10 
(0.005) 
  14  
0.68   32 
  4 0.33 
(0.013)
 
 
  31  0.27 
(0.001) 
  26 0.45 
(0.012) 
  43 
1.05   20 
  6 0.43 
(0.015) 
  43  0.31 
(0.014) 
  31 0.26 
(0.011) 
  26 
1.00     0 
10 0.34 
(0.014) 
  66 0.11 
(0.002) 
  22 0.07 
(0.106) 
  13 
0.52   48 
16 0.21  
(0.019) 
  15  0.27 
(0.107) 
  20 0.89 
(0.015) 
  65 
1.37   13 
24 0.32 
(0.104) 
  36 0.07 
(0.036) 
    8 0.51 
(0.039)
a
 
  57 
0.90   10 
a
 Values in parenthesis indicate standard deviations (n = 3) 
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Stability of NMOR 
To determine NMOR stability, a known amount of NMOR was added to individual 
fractions of the egg. The amount of NMOR in the egg white and yolk were constant for 
the duration of the experiment (Fig. 4), suggesting stability in both fractions.  
 
 
 
 
NMOR Transfer among Egg Fractions 
           The amount and concentration of NMOR in the egg white decreased with time. 
Membrane-associated NMOR increased up to 24 h after which it decreased. The amount 
and concentration of NMOR within the yolk steadily increased with time up to 120 h 
(Fig. 5).  
 
 
 
Fig. 4. NMOR in albumin (egg white) (●) and yolk (○) in a 24-h experiment. Error bars 
indicate mean standard deviations; where absent bars fall within symbols. 
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Fig. 5: NMOR concentrations (µg/g) in the albumin (egg white), membrane and yolk, 
and total NMOR (mg) in the albumin (egg white) (●), membrane (○) and yolk (▼) 
during 120 h of incubation. Error bars indicate mean standard deviations; where absent 
bars fall within symbols. 
           
          The total amount of NMOR in the egg remained constant for the first 24 h then 
decreased through the remainder of the 120-h experiment (Table IX). 
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TABLE IX. Total NMOR in the egg during a 120-h experiment (1 mg added) 
Time 
 
Amount of 
NMOR in egg 
NDMA Lost or Unaccountable 
 
(h) (mg) (mg) (%) 
 1 0.88 (0.004)
a
 0.12 12 
 4 0.81 (0.013) 0.19 19 
 6 0.84 (0.054) 0.16 16 
10 1.18 (0.014) 0.06   5 
24 1.15 (0.012) 0.10   8 
48 0.78 (0.019) 0.22 22 
72 0.79 (0.121) 0.21 21 
120 0.79 (0.118) 0.21 21 
a
 Values in parenthesis indicate standard deviations (n = 3) 
 
Transfer between Fractions 
          On analyzing the distribution of NMOR between the egg white and membrane 
(Table X), NMOR transferred from the egg white to the membrane. NMOR differed from 
NDMA as less NMOR transferred from the egg white to the membrane. NMOR 
transferred from the membrane to the yolk during the 24-h incubation period. The results 
suggest dynamic movement of NMOR between the membrane and yolk (Table XI). 
Transfer to the yolk also was observed in the egg white-yolk matrix (Table XII). 
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TABLE X. NMOR transfer from the egg white to the membrane during a 24-h 
experiment (1 mg added) 
 Egg white Membrane Total 
Time Amount Relative 
Percent 
Amount Relative 
Percent 
Amount Loss 
(h) (mg) (%) (mg) (%) (mg) (%) 
  1 0.49 (0.009)
a
 68 0.23 (0.029) 32 0.72 28 
  4 0.58 (0.053) 75 0.19 (0.009) 25 0.77 23 
  6 0.54 (0.009) 64 0.30 (0.001) 36 0.84 16 
10 0.61 (0.015) 75 0.20 (0.007) 25 0.81 19 
16 0.53 (0.035) 71 0.22 (0.071) 29 0.75 25 
24 0.52 (0.139) 71 0.22 (0.001) 30 0.74 26 
a
 Values in parenthesis indicate standard deviations (n = 3) 
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TABLE XI. NMOR transfer from the membrane to the yolk during a 24-h 
experiment (1 mg added) 
 Membrane Yolk Total 
Time Amount Relative 
Percent 
Amount Relative 
Percent 
Amount Loss 
(h) (mg) (%) (mg) (%) (mg) (%) 
  1 0.46 (0.017)
a
 53 0.41 (0.037) 47 0.87 13 
  4 0.41 (0.006) 49 0.43 (0.091) 51 0.84 16 
  6 0.29 (0.055) 26 0.82 (0.040) 74 1.11 14 
10 0.40 (0.012) 50 0.40 (0.011) 50 0.8 20 
16 0.56 (0.135) 65 0.30 (0.021) 35 0.86 14 
24 0.37 (0.002) 42 0.52 (0.012) 58 0.89 11 
a
 Values in parenthesis indicate standard deviations (n = 3) 
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Table XII. NMOR transfer from the egg white to the yolk during a 24-h experiment 
(1 mg added) 
 Egg white Membrane Yolk Total 
Time Amount Relative 
Percent 
Amount Relative 
Percent 
Amount Relative 
Percent 
Amount 
 
Loss 
(h) (mg) (%) (mg) (%) (mg) (%) (mg) (%) 
 1 0.49 
(0.001)
a
 
64 0.13 
(0.012) 
17 0.15 
(0.002) 
20 
0.77 23 
 4 0.56 
(0.013) 
78 0.07 
( 0.015) 
10 0.09 
(0.009) 
13 
0.72 28 
 6 0.53 
(0.012) 
62 0.12 
(0.151) 
14 0.21 
(0.006) 
24 
0.86 14 
10 0.58 
(0.009) 
74 0.08 
(0.004) 
10 0.12 
(0.010) 
15 
0.78 22 
24 0.57 
(0.003) 
76 0.10 
(0.041) 
13 0.08 
(0.070) 
11 
0.75 25 
a
 Values in parenthesis indicate standard deviations (n = 3) 
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Stability of NNAT 
To determine the stability of NNAT in the various fractions of the egg, a known amount 
was added to each fraction and the amount remaining was determined with time. The 
amounts of NNAT in the egg white and yolk decreased slightly during the first 10 h, but 
then remained relatively constant for at least 24 h (Fig. 6). 
 
 
Fig. 6. NNAT in albumin (egg white) (●) and yolk (○) in a 24-h experiment. Error bars 
indicate mean standard deviations; where absent bars fall within symbols. 
 
NNAT Transfer among Egg Fractions 
          In the egg white and membrane, the amount of NNAT reached a maximum at 4 h 
and then progressively decreased (Fig. 7). The amount of NNAT decreased in the yolk 
after 1 h. After 24 h no NNAT was detected in any fraction. The lack of change in 
atrazine concentrations (atrazine was an impurity in NNAT) indicated that NNAT was 
not decomposing to atrazine.  
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Fig. 7. NNAT concentrations (µg/g) in the albumin (egg white), membrane and yolk, and 
total NNAT (mg) in the albumin (egg white) (●), membrane (○) and yolk (▼) during 120 
h of incubation. Error bars indicate mean standard deviations; where absent bars fall 
within symbols. 
 
          The total amount of NNAT in the egg decreased during the 24 h experiment and 
none was detected after 24 h (Table XIII). 
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Table XIII. Total NNAT in the egg during a 24-h experiment (1 mg added) 
Time 
Amount of 
NNAT in egg 
Amount of NNAT lost/ 
unaccounted for 
(h) (mg) (mg) (%) 
  1 0.08 (0.007)
a
 0.92 92 
  4 0.08 (0.009) 0.92 92 
  6 0.01 (0.003) 0.99 99 
10 0.01 (0.001) 0.99 99 
16 0.01 (0.001) 0.99 99 
24 0.0 0 (0.001) 1.00 100 
a
 Values in parenthesis indicate standard deviations (n = 3) 
 
Transfer between Fractions 
          On analyzing the distribution of NNAT between two layers, the amount of NNAT 
in the egg white decreased while the amount in the membrane increased within the first 4 
h in the egg white-membrane matrix (Table IV). Within 4 h, the amounts of NNAT in the 
egg white and the membrane decreased and neither could be detected after 24 h. This 
shows that although NNAT transferred from the egg white into the membrane within the 
first few hours, NNAT degraded on longer incubation. In the membrane-yolk matrix, the 
amount of NNAT in the membrane fraction decreased with time while that in the yolk 
remained relatively constant after an initial increase (Table XV), suggesting transfer from 
the membrane to the yolk. The distribution of NNAT between the egg white and yolk 
also indicated increased transfer from the egg white into the yolk with time (Table XVI).  
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TABLE XIV. NNAT transfer from the egg white to the membrane in a 24-h 
experiment (1 mg added) 
 Egg white Membrane Total 
Time Amount Relative 
Percent 
Amount Relative 
Percent 
Amount Loss 
(h) (mg) (%) (mg) (%) (mg) (%) 
1 0.31 (0.003)
a
 84 0.06 (0.010) 16 0.37  63 
4 0.23 (0.075) 70 0.1 (0.011) 30 0.33  67 
10 0.02 (0.030) 50 0.02 (0.050) 50 0.04  96 
16 0.01 (0.001) - Not detected - -  99 
24 Not detected - Not detected - - 100 
a
 Values in parenthesis indicate standard deviations (n = 3) 
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Table XV.  NNAT transfer from the membrane to the yolk during a 24-h 
experiment (1 mg added) 
 Membrane Yolk Total 
Time Amount Relative 
Percent 
Amount Relative 
Percent 
Amount Loss 
(h) (mg) (%) (mg) (%) (mg) (%) 
 1 0.26 (0.002)
a
 87 0.04 (0.004) 13 0.30 70 
 4 0.13 (0.007) 48 0.14 (0.006) 52 0.27 73 
10 0.07 (0.070) 39 0.11 (0.051) 61 0.18 82 
16 0.13 (0.018) 42 0.18 (0.005) 58 0.31 69 
24 0.05 (0.011) 39 0.08 (0.008) 61 0.13 87 
a
 Values in parenthesis indicate standard deviations (n = 3) 
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Table  XVI. NNAT transfer from the egg white to the yolk during a 24-h experiment 
(1 mg added) 
 Egg white Membrane Yolk Total 
Time Amount Relative 
Percent 
Amount Relative 
Percent 
Amount Relative 
Percent 
Amount 
 
Loss 
(h) (mg) (%) (mg) (%) (mg) (%) (mg) (%) 
 1 0.06 
(0.003)
a
 
60 0.01 
(0.001) 
10 0.03 
(0.010) 
30 
0.1 90 
 4 0.03 
(0.001) 
50 0.01 
(0.070) 
17 0.02 
(0.027) 
33 
0.06 94 
10 0.02 
(0.012) 
40 0.01 
(0.053) 
20 0.02 
(0.004) 
40 
0.05 95 
16 0.02 
(0.070) 
40 0.01 
(0.006) 
20 0.02 
(0.021) 
40 
0.05 95 
 
24 
Not 
detected 
 
- 
0.01 
(0.016) 
33 
 
0.02 
(0.001) 
67 
 0.03 97 
a
 Values in parenthesis indicate standard deviations (n = 3) 
 
The distribution of the nitrosamines in unfertilized chicken eggs indicates that while most 
of the NDMA and NMOR remained in the egg white, NNAT rapidly moved into the 
yolk. The total amount of NNAT decreased with time (Fig. 8). 
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Fig. 8. Distribution of NDMA, NMOR and NNAT in the albumin (egg white) (♦), 
membrane (■) and yolk (▲) during a 24-h incubation. 
 
          A comparison among the three compounds shows that NDMA and NMOR are 
similar in their transfer behavior in that both have a greater affinity for the yolk fraction 
over the egg white fraction (Table XVII). Although the concentration of NNAT is very 
low compared to NDMA and NMOR, it readily moves into the yolk. The larger Yolk/Egg 
white distribution coefficient for NNAT indicates that it has a greater affinity for yolk 
(larger bioconcentration potential) than NDMA or NMOR. 
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Table  XVII. Maximum nitrosamine concentrations in the egg fractions 
Highest concentration NDMA NMOR NNAT 
Egg white (µmol/g) 0.24 (0.02)
a
 0.4 (0.02) 0.03 (0.02) 
Membrane (µmol/g) 0.22 (0.15) 0.24 (0.02) 0.002 (0.02) 
Yolk (µmol/g) 0.26 (0.005) 0.46 (0.02) 0.11(0.02) 
Yolk/Egg white  
(Distribution coefficient) 
1.08 1.15 3.67 
a
 Values in parenthesis indicate standard deviations (n = 3) 
 
The biological effects of nitrosamines depend in part on their stability and transfer 
behavior. The studies with unfertilized chicken eggs indicate that NDMA, NMOR and 
NNAT partition from the egg white into the yolk because temporal decreases in their 
amounts in the egg white and membrane were accompanied by concomitant increases in 
the yolk. All three compounds were also fairly stable in the yolk fraction. NNAT has a 
higher affinity than NDMA and NMOR for the more lipophilic yolk fraction, consistent 
with its octanol-water partition coefficient (Kow). This suggests that it may have a greater 
potential to bioconcentrate than NDMA and NMOR.  
          A loss in the total amount of the nitrosamines with time suggests that they may be 
decomposing or denitrosating. Haussmann and Werringloer (1987) and Appel et al. 
(1991) demonstrated two possible pathways by which nitrosamines denitrosate in 
biological media:  one electron reduction that produces NO and the secondary amine or 
one electron abstraction that liberates NO via an oxidative mechanism involving the 
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formation of a primary amine and the corresponding aldehyde. Because the parent 
compounds of the nitrosamines were not detected in this study, decomposition or 
denitrosation in the yolk likely occurred via an oxidative mechanism (i.e. one electron 
abstraction). This mechanism also liberates NO, which may subsequently affect 
development of chicken embryos.  
 
 Teratogenic Potential of Selected Nitrosamines 
From the studies with unfertilized eggs, it was determined that all three nitrosamines 
partition into the yolk where they are all fairly stable. Decreases in the total amounts of 
nitrosamines may be due to denitrosation or decomposition. It was hypothesized that the 
presence of the nitrosamine may alter NO levels and affect development. Thus, studies 
were conducted with fertilized chicken eggs to determine the impact of the three 
nitrosamines on the development of chicken embryos. The embryos were harvested at 
days 3 and 5 and examined microscopically for any soft tissue or skeletal abnormalities. 
          All three nitrosamines adversely affected development of the chicken embryos to 
varying degrees. Malformations were observed in embryos exposed to much lower 
concentrations of NNAT than NDMA or NMOR. 
  
Impact of NDMA on developing embryos 
Fertilized chicken eggs were treated with 12.5, 25.0, or 50.0 µg NDMA in 50 µL of DD 
water. Mortality and deformities were observed only in embryos treated with 25 µg and 
higher doses of NDMA (Fig 9). 
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Fig. 9. Impact of NDMA dose (in 50 µL DD water) on chicken embryo mortality (     ) 
and malformations (   ) 
 
          The most common defects observed on exposure to NDMA included gastroschisis 
(33%), heart defects, neural tube defects (22% each), microphthalmia (11%) and caudal 
regression (11%). 
          Analysis of the frequency of mortality or abnormalities resulting from NDMA 
exposure using chi square test (SAS, Cary, NC) indicated that NDMA does not 
significantly affect development in chicken embryos (p > 0.05). There was also no 
difference within treatments; i.e., between dosage groups of NDMA (p > 0.05) and thus 
there was no dose – response relationship. No significant association was observed 
between exposure to NDMA and embryo mortality observed in the embryos (p > 0.05). 
Analysis of the relative risk of mortality or abnormalities from exposure to NDMA is 
very low (RR < 1.0, 95% CI).  
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Impact of NMOR on developing embryos 
Fertilized chicken eggs were treated with 25, 250, 1250, 2500, 5000, and 7500 µg NMOR 
in 50µL DD water. Mortality and abnormalities were observed in embryos treated with 
high doses of NMOR (≥2500 µg) (Fig 10). 
 
Fig. 10. Impact of NMOR dose (in 50 µL DD water) on chicken embryo mortality (    ) 
and malformations (   ) 
 
          Gastroschisis was the most frequently occurring malformation (30%), followed by 
heart defects (~ 26%). Other defects observed include neural tube defects, 
microphthalmia and caudal regression (11, 11, and 22%, respectively).  
          A chi square test was used to assess relationships between exposure to varying 
doses of NMOR and the effects observed (mortality and malformations). On comparing 
overall exposure to NMOR and subsequent effects (mortality and deformity), NMOR had 
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a significant adverse effect on the developing embryos (p < 0.05). There also was a 
difference between doses of NMOR (p < 0.05) with respect to the effect they produce.  
          NMOR exposure (combining all doses) was associated with embryo death (p < 
0.05). There also was a significant dose – response relationship; larger doses of NMOR 
induced a high level of mortality in exposed chicken embryos. An analysis of relative risk 
indicated a greater risk of mortality in embryos treated with NMOR than in the controls 
(RR < 1.0, 95% CI).  
          NMOR exposure (combining all doses) was associated with malformations (p < 
0.05). However, there were no significant differences among the NMOR doses. Relative 
risk analysis indicated that the chance of the embryos being malformed is greater for 
embryos treated with NMOR than for controls (95% CI). A comparison (by chi square 
test) of each NMOR dose with the control shows that there is a significant association 
between exposure and malformations and mortality at doses ≥2500 µg.  
 
Impact of NNAT on developing embryos 
Fertilized chicken eggs were treated with 0.06, 0.01, 0.23, 0.46, 0.91, 1.82, 3.63, 5.50, 
7.25, and 14.50 µg NNAT in 50µL DD water. Adverse effects (mortality and 
malformations) were observed in embryos exposed to doses as low as 0.06 µg NNAT 
(Fig 11). NNAT exposure resulted in malformations at lower doses than NDMA or 
NMOR, therefore of the three nitrosamines, NNAT was the most potent embryotoxic 
compound. 
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Fig. 11. Impact of NNAT dose (in 50 µL DD water) on mortality (    ) and malformations 
(   ) 
 
          Heart defects (ectopic and abnormally looped heart) and gastroschisis (each 24%) 
were the most frequently observed defects observed following exposure to NNAT. Other 
defects include caudal regression (19%), craniofacial hypoplasia, microphthalmia (each 
11%) and neural tube defects (8%). Some of the embryos (4%) showed anophthalmia, 
which was not observed in embryos exposed to either NDMA and NMOR. Some of the 
defects are shown in Fig 12.    
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Normal 5 day old embryo NNAT 3.63 µg/50 µL 
1 
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5 
6 
NNAT 1.82 µg/50 µL 
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4 
5 
NNAT 0.91 µg/50 µL 
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Fig. 12. Malformations in 5-day-old chicken embryos following exposure to NNAT. 1= 
neural tube defect, 2=craniofacial hypoplasia, 3=microphthalmia, 4=ectopic heart, 5= 
gastroschisis, 6=caudal regression 
 
          A chi square test was used to evaluate the impact of NNAT on mortality and 
malformations in chicken embryos. Exposure to NNAT adversely affected (mortality and 
malformation) chicken embryos (p < 0.05), although there is no clear dose-response 
relationship between various doses of NNAT and either lethality or observed 
abnormalities. 
          The relationship between mortality and NNAT exposure was evaluated using a chi 
square test and relative risk analysis. There was an association between NNAT exposure 
(all doses) and embryo mortality (p < 0.05) but there was no difference among the doses. 
NNAT 0.46 µg/50 µL NNAT 0.06 µg/50 µL 
1 
3 
2 
4 
5 
6 
1 
3 
4 
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Relative risk analysis showed a greater chance of mortality in chicken embryos exposed 
to NNAT (the chance of control embryos remaining alive was 1.1 times greater than 
those exposed to NNAT (95% CI)).  
          Analysis of the impact of NNAT (all doses) on malformations showed a significant 
association (p < 0.05) between exposure to NNAT and subsequent deformity. However, 
there was no significant association between NNAT dose and defect. Assessment of 
relative risk indicates that the chance of an embryo developing normally is 1.3 times 
greater for controls than for those treated with NNAT (95% CI); i.e. the risk of 
malformations from exposure to NNAT is greater than if there is no exposure. A 
comparison (chi square test) of each NNAT dose with the control showed a significant 
association between exposure and defect at 0.46, 0.91, 3.63, 5.50, and 7.25 µg in 50 µL 
DD water.  
There is conflicting evidence about the adverse effects of atrazine. Atrazine may 
be an endocrine disrupter in some animal models (mainly amphibian) (Gammon et al. 
2005). Atrazine has been shown to affect development in rats and rabbits (delayed 
skeletal ossification) and the reproductive NOEL is 25 mg/kg body weight/d (Gammon et 
al. 2005). The present studies with chicken embryos showed that 16.5 µg atrazine was 
neither teratogenic nor lethal to chicken embryos.  
          Teratogenic potential and lethality varied among the three nitrosamines tested. 
NDMA, a known hepatotoxin and carcinogen, was neither lethal nor teratogenic in 
chicken embryos at the doses administered. Previous work with chicken embryos showed 
that NDMA is lethal or inhibits growth (Maduagwu and Bassir 1979). Inoculating White 
Leghorn chicken eggs with 2.25 mg/mL NDMA (similar to the methodology of the 
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present studies) on the tenth day of development resulted in 100% mortality. However, 
these effects were not observed in the present study. NMOR was teratogenic and lethal at 
relatively high doses (≥2500 µg). NNAT proved to be the most potent teratogen (lowest 
dose at which malformations were observed was 0.455 µg). There was no clear dose- 
response relationship with NNAT because it was teratogenic at 0.91 µg but not at the 
higher dose of 1.82 µg. It also induced defects at doses of 3.63 µg to 7.25 µg but not at 
the largest dose of 14.50 µg.  
Despite the lack of a clear dose-response relationship between NNAT and the 
observed teratogenic effects, this study shows that exposure to NNAT or the endogenous 
formation of NNAT could be potentially harmful. Research is limited regarding exposure 
to atrazine and NNAT and the potential for in vivo formation of NNAT from exposure to 
atrazine and nitrate. Atrazine, due to its weak basicity, nitrosates rapidly (200 times faster 
than dimethylamine at pH 2 (Mirvish et al. 1991) and thus exposure to atrazine poses a 
risk for endogenous formation of NNAT. High concentrations of atrazine (1500 µg/kg) 
have been detected in well water in Wisconsin, where some wells also have high nitrate 
levels (Meisner et al. 1993). This creates the potential for NNAT formation after 
ingestion. As observed in experiments with unfertilized eggs, NNAT has a high affinity 
for the lipophilic yolk fraction and rapidly moves into the yolk in a short period of time. 
NNAT showed a greater bioconcentration potential than NDMA and NMOR, which may 
be contributing to the occurrence of the biological effects observed in the experiments 
with fertilized eggs.  
          Several factors may explain the variability in observed effects of the nitrosamines 
on the chicken embryos, despite measures taken to control treatment conditions. Embryo 
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maturity at the time of treatment/exposure will vary due to small differences in 
temperature. There is variability in embryo robustness and genetic susceptibility to a 
particular compound or to certain developmental defects. Variability may result from the 
combined effects of multiple factors. These factors cannot be excluded with certainty as 
contributors to the variability in observed defects. Despite these drawbacks, the chicken 
embryo is a useful model for preliminary screening of compounds for teratogenicity. For 
a clearer, in-depth understanding of potential teratogenic effects of these and other 
environmentally relevant nitrosamines, further study with murine models are warranted 
as are epidemiological studies to evaluate associations between nitrosamine exposure and 
birth defects.  
 
Impact of NNAT on nitrotyrosine concentrations in chicken embryos 
Teratology studies with chicken embryos showed a significant association between 
exposure to NNAT and developmental abnormalities. Because transfer studies show 
NNAT bioconcentration in yolk and suggest loss with time may be due to denitrosation 
or nitrosamine decomposition, it was hypothesized that the defects observed in chicken 
embryos may be due to alterations in NO concentrations. As previously mentioned, 
measurement of the stable 3-nitrotyrosine is a useful way to provide evidence of NO-
dependent damage and may reflect one pathway by which NNAT exerts teratogenic 
effects. Nitrotyrosine was measured in tissue sonicates from five-day-old chicken 
embryos treated with DD water (controls), embryos exposed to NNAT that appeared 
normal, and embryos exposed to NNAT that were malformed.  
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          Malformed five-day-old embryos had higher concentrations of nitrotyrosine than 
normal-appearing embryos of the same treatment group (Fig. 13). Paired t-tests were used 
to compare nitrotyrosine values in normal and malformed embryos for each treatment. 
Malformed embryos treated with 0.06, 0.46, 0.91 and 3.63 µg NNAT had significantly 
higher concentrations of nitrotyrosine than treated embryos that appeared normal. 
 
Fig. 13. Nitrotyrosine concentrations in malformed 5-day-old embryos exposed to NNAT  
 
          One-way analysis of variance (ANOVA) showed that nitrotyrosine concentrations 
in normal-appearing embryos treated with 0.06, 0.46 and 3.63 µg NNAT were 
significantly smaller than those in controls (p < 0.05). Nitrotyrosine concentrations were 
greater (p < 0.05) in malformed embryos treated with 0.46 and 0.91 µg NNAT than in the 
controls. What comprises “normal” nitrotyrosine concentrations in developing chicken 
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embryos is uncertain. In our study we observed high levels of nitrotyrosine in the controls 
which could indicate stress induced by rapid mitotic divisions and subsequent cellular 
differentiation during embryogenesis and organogenesis. At higher doses of NNAT 
exposure, where nitrotyrosine concentrations were observed to be lower than controls, 
other mechanisms of denitrosation/dealkylation may be influencing NO and subsequently 
nitrotyrosine levels.  
         One-way ANOVA analysis also was used to compare nitrotyrosine concentrations 
in embryos (normal and malformed combined) receiving different doses of NNAT. 
Nitrotyrosine was greater (p < 0.05) in embryos treated with 0.91 µg NNAT than in 
embryos treated with 0.06 µg NNAT. Embryos treated with 0.23, 0.46 and 0.91 µg 
NNAT had significantly larger concentrations of nitrotyrosine than those treated with the 
largest dose of NNAT (3.63 µg). The large 3.63 µg dose may have induced a different 
deleterious response, resulting in overall lower nitrostyrosine concentrations. 
          The ANOVA showed that nitrotyrosine levels were significantly larger in treated 
malformed embryos than in treated, normal-appearing embryos. These experiments show 
that exposure to NNAT can affect nitrotyrosine concentrations in five-day-old chicken 
embryos. NO-mediated stress may reflect one pathway by which NNAT exerts 
teratogenic effects.  
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CONCLUSIONS AND RECOMMENDATIONS 
The main objectives of this study were to use unfertilized chicken eggs and developing 
chicken embryos to evaluate the stability, biological transfer and potential teratogenicity 
of three environmentally relevant nitrosamines: NDMA, NMOR and NNAT. 
Experiments using unfertilized chicken eggs showed that all three nitrosamines transfer 
from the egg white into the yolk where they are relatively stable. NNAT has a greater 
potential to bioconcentrate than NDMA and NMOR due to its higher affinity for the yolk 
fraction of the egg. A decrease in the total amounts of the three nitrosamines in the egg 
yolk suggests that they may be denitrosating (or otherwise decomposing) and releasing 
NO. Alterations in NO levels can affect intracellular signaling and adversely impact 
embryonic and fetal development. Studies with fertilized chicken eggs showed the three 
nitrosamines were detrimental to the development of chicken embryos to varying 
degrees. Observed abnormalities include neural tube defects, craniofacial hypoplasia, 
microphthalmia, anophthalmia, heart defects, gastroschisis, and caudal regression. 
Malformations were observed in embryos exposed to much lower concentrations of 
NNAT than NDMA or NMOR proving that NNAT was the most potent teratogen.  
Exposure to NNAT was associated with developmental abnormalities in chicken 
embryos. However, atrazine, the parent compound of NNAT, did not affect development. 
It was hypothesized that defects observed in chicken embryos may be due to alterations 
in NO concentrations resulting from exposure to NNAT. Subsequent test showed 
significantly higher levels of nitrotrotyrosine, a stable marker of NO and subsequent 
nitrosative stress, in NNAT-treated, five-day-old embryos with malformations than in 
treated, normal-appearing embryos.  
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          Considering the increasing prevalence of nitrates in ground and drinking water and 
the widespread use of atrazine, data are inadequate about potential exposure to NNAT. 
Epidemiological studies concerning potential exposure to NNAT and other nitrosamines 
are needed. Laboratory studies also need to be conducted to quantify the exposure and 
kinetics of a given dose of the nitrosamine absorbed by chicken/rodent embryos, which 
can then be used to estimate exposure levels in humans. Although much is known about 
the carcinogenic effects of nitrosamines, there is limited research regarding their 
teratogenic impacts and the mechanisms by which they induce abnormal development. 
More epidemiological studies are needed to assess the association between exposure to 
these and other nitrosamines and adverse fetal outcomes.  
NNAT may be teratogenic and nitrotyrosine, a marker of NO-dependent oxidative 
stress, may reflect one pathway through which nitrosamines could exert their teratogenic 
effects. Further studies are needed to understand this and other possible mechanisms. The 
activation of guanylyl cyclase by low concentrations of NO is the major pathway of NO 
signaling that is involved in the regulation of many physiological functions. An increase 
or decrease in the NO levels due to nitrosamine exposure could disrupt the normal 
activation of guanylyl cyclase. Levels of NO and guanylyl cyclase could be determined 
after nitrosamine exposure to evaluate this possible mechanism.  
Apoptosis is crucial during development (sculpting digits and extremities and 
governing the connection between central nervous system, distal structures and cardiac 
development). Therefore another focus for future investigations would be to extend areas 
of apoptosis leading to malformations. Depending on which organ is malformed, 
embryos (chicken or rodent) can be evaluated for disruption of apoptosis in the 
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primordial tissues that develop into the affected tissue. Cellular injury resulting from 
reactive nitrogen species is another parameter that can be studied.  
          The unfertilized chicken egg model provides a useful model to study the biological 
stability and transfer of chemical compounds. While the chicken embryo is a faster and 
relatively inexpensive model to screen compounds for potential teratogenicity, further 
studies with murine models are required to reach firm conclusions regarding the 
teratogenic behavior of nitrosamines. 
 
 
 
 
 
  
72 
 
REFERENCES 
Alexander PG, Chau L, Tuan RS. 2007. Tole of nitric oxide in chick embryonic 
organogenesis and dysmorphogenesis. Birth Defects Res (Part A) 79:581-594. 
Alvarez SM, Burd RS. 2007. Increasing prevalence of gastroschisis repairs in the United 
States: 1996-2003. J Pediatr Surg 42: 943-946.  
Annola K, Heikkinen AT, Partanen H, Woodhouse H, Segerback D, Vahakangas K. 
2009. Transplacental transfer of nitrosodimethylamine in perfused human placenta. 
Placenta 30: 277-283.  
Appel KE, Gorsdorf S, Scheper T, Spiegelhalder B, Wiessler M, Schoepke M, Engehom 
C, Kramer R. 1991. Metabolic denitrosation of N-nitrosamines: Mechanism and 
biological consequences. In O’Neill IK, Chen J, Bartsch H (eds) Relevance to human 
cancer of N-nitroso compounds, tobacco smoke and mycotoxins, IARC Scientific 
Publications, Lyon 105: 351-357.  
Archer MC, Chin W, Lee VM. 1994. Possible mechanisms of N-nitrosodimethylamine 
hepatotoxicity. In: Loeppky RN, editor. Nitrosamines and related N-nitroso compounds. 
Washington, DC: ACS Symposium Series 553, American Chemical Society. p 279- 289. 
Asami M, Oya M, Kosaka K. 2009. A nationwide survey of NDMA in raw and drinking 
water in Japan. Sci Total Environ 407: 3540-3545.  
Best PJM, Berger PB, Miller VM, Lerman A. 1998. The effect of estrogen replacement 
therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann 
Intern Med 128: 285-288. 
73 
 
Bieniarz K, Epler P, Kime D, Mikolajczyk MS, Popek W, Mikolajczyk. 1996. Effects of 
N, N-Dimethylnitrosamine on in vitro oocyte maturation and embryonic development of 
fertilized eggs of carp (Cyprinus carpio) kept in eutrophied ponds. J Appl Toxicol 16: 
153-156.  
Blicharz KD, Rachubik J, Kowalski B. 2005. Occurrence of volatile N-nitrosamines in 
polish tinned foods. Bull Vet Inst Pulawy 49: 319-322.  
Bossert NL, Iannaccone PM. 1985. Midgestational abnormalities associated with in vitro 
preimplantation N-methyl-N-nitrosourea exposure with subsequent transfer to surrogate 
mothers. Proc Natl Acad Sci 82: 8757-8761.  
Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 72: 
248–254. 
Braman RS, Hendrix SA. 1989. Nanogram nitrite and nitrate determination in 
environmental and biological materials by vanadium (III) reduction with 
chemiluminescence detection. Anal Chem 61: 2715-2718. 
Brambilla G, Cajelli E, Finolllo R, Maura A, Pino A, Robbbiano L. 1985. Formation of 
DNA damaging nitroso compounds by interaction of drugs with nitrite: A preliminary 
screening for detecting potentially hazardous drugs. J Toxicol Environ Health 15: 1-24. 
Brender JD, Olive JM, Felkner M, Suarez L, Markwardt W, Hendricks KA. 2004b. 
Dietary nitrites and nitrates, nitrosatable drugs, and neural tube defects. Epidemiology 15: 
330-336.  
74 
 
Brunnemann KD, Scott JC, Hoffmann D. 1982. N-Nitrosomorpholine and other volatile 
N-nitrosamines in snuff tobacco. Carcinogenesis 3: 693-696.  
Bulushi IA, Poole S, Deeth HC, Dykes GA. 2009. Biogenic amines in fish: Roles in 
intoxication, spoilage and nitrosamines formation - A review. Crit Rev Food Sci Nutr 49: 
369-377.  
Carozza SE, Olshan AF, Faustman EM, Gula MJ, Kolonel LN, Austin DF, West ED, 
Weiss NS, Swanson GM, Lyon JL, Whyte TH, Gilles FH, Aschenbrener C, Leviton A. 
1995. Maternal exposure to N-nitrosatable drugs as a risk factor for childhood brain 
tumors. Int. J Epidemiol 24: 308-312.  
Caussy D. 2003. Case studies of the impact of understanding bioavilability: Arsenic. 
Ecotoxicol Environ Safety 56: 164-173.    
Challis BC, Edwards A, Hunma RR, Kryptopolous SS and Outram JR. 1978. Rapid 
formation of N-nitrosamines from nitrogen oxides under neutral and alkaline conditions. 
In: Walker EA, Castegnaro M, Griciute L and Lyle RE, editors. Environmental Aspects 
of N-nitroso Compounds. France: International Agency for Research on Cancer. p 127-
142.  
Collins SR, Griffin MR, Arbogast PG, Walsh WF, Rush MR, Carter BS, Dudley J, 
Cooper WO. 20007. The rising prevalence of gastroschisis and omphalocele in 
Tennessee. J Pediatr Surg 42: 1221-1224.  
75 
 
Cooney RV, Ross PD. 1987. N-nitrosation and N-nitration of morpholine by nitrogen 
dioxide in aqueous solution: Effects of vanillin and related phenols. J Agric Food Chem 
35: 789-793.  
Corpas FJ, Barroso JB, Carreras A, Quiros M, Leon AM, Romero-Puertas MC, Esteban 
FJ, Valderrama R, Palma JM, Sandalio LM, Gomez M, Rio L. 2004. Cellular and 
subcellular localization of endogenous nitric oxide in young and senescent pea plants. 
Plant Physiol 136: 2722-2733 
Corpas FJ, Barroso JB, Carreras A, Valderrama R, Palma JM, Leon AM, Sandalio LM, 
Rio L. 2006. Constitutive arginine-dependent nitric oxide synthase activity in different 
organs of pea seedlings during plant development. Planta 224: 246-254 
Cowdin RM, Pogoda JM, Lijinsky W, Holly EA, Mueller BA, Martin SP. 2003. Maternal 
prenatal exposure to nitrosatable drugs and childhood brain tumors. Int J Epidemiol 32: 
211-217.   
Croen LA, Todoroff K, Shaw GM.  2001. Maternal exposure to nitrate from drinking 
water and diet and risk for neural tube defects.  Am J Epidemiol 153: 325-331.  
Dawson BA, Lawrence RC. 1987. Analysis of selected drug formulations for volatile 
nitrosamines. J Assoc Off Anal Chem 70: 554-556.   
Dijkstra G, Moshage H, Dullemen HMV, Krikken ADJ, Tiebosch ATMG, Kleibeuker 
JH, Jansen PLM, Goor HV. 1998. Expression of nitric oxide synthases and formation of 
nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 186: 
416-421.  
76 
 
Fajen JM, Carson GA, Rounbehler DP, Fan TY, Vita R, Goff UE, Wolf MH, Edwards 
GS, Fine DH, Reinhold V, Biemann K. 1979. N-nitrosamines in the rubber and tire 
industry. Science 205: 1262-1264. 
Fantel AG, Person RE. 2002. Further evidence for the role of free radicals in the limb 
teratogenicity of L-NAME. Teratology 66: 24–32. 
Farombi EO, Shrotriya S, Surh YJ. 2009. Kolaviron inhibits dimethyl nitrosamine 
induced liver injury by suppressing COX-2 and iNOS expression via κ- B and AP-1. Life 
Sciences 84: 149-155.  
Feng D, Wang H, Cheng X, Wang J, Ning L, Zhou Q, Zhou Y, Yang Q. 2009. Detection 
and toxicity assessment of nitrosamines migration from latex gloves in the Chinese 
market. Int J Hyg Environ Health 212: 533-540.  
Fristachi A, Rice G. 2007. Estimation of the total oral intake of NDMA attributable to 
drinking water. J Water Health 5: 341-355. 
Gal A, Tamir S, Kennedy LJ, Tannenbaum SR, Wogan GN. 1997. Nitrotyrosine 
formation, apoptosis, and oxidative damage: Relationships to nitric oxide production in 
SJL mice bearing the RcsX tumor. Cancer Res 57: 1823-1828.  
Gammon DW, Aldous CN, Carr WC, Sanborn JR, Pfeifer KF. 2005. A risk assessment of 
atrazine use in California: human health and ecological aspects. Pest Manag Sci 61: 331-
355.  
77 
 
Gardner JS, Boileau BG, Alderman BW, Fernbach SK, Greene C, Mangione EJ. 1998. 
Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse 
and risk of craniosynostosis. Int J Epidemiol 27: 64-67.  
Gosselin DC, Headrick J, Tremblay R, Chen X, Summerside S. 1997. Domestic well 
water quality in rural Nebraska: Focus on nitrate-nitrogen, pesticides and coliform 
bacteria. Ground Water Monit Remediat 17: 77–87.  
Greenlee AR, Ellis TM, Berg RL. 2004. Low dose agrochemicals and lawn care 
pesticides induce developmental toxicity in murine pre-implantation embryos. Environ 
Health Persp 112: 703-709.  
Griesenbeck JS, Steck MD, Huber JC, Sharkey JR, Rene AA, Brender JD. 2009. 
Development of estimates of dietary nitrates, nitrites and nitrosamines for use with the 
short willet food frequency questionnaire. Nutrition J 8: 1-9. 
Grosjean D.1991. Atmospheric chemistry of toxic contaminants 6. Nitrosamines: Dialkyl 
nitrosamines and nitrosomorpholine. Air Waste Manage Assoc 41: 306-311.  
Halliwell B. 1997. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of 
peroxynitrite formation in vivo? FEBS Letters 411: 157-160.  
Hamburger V, Hamilton H. 1951. Series of embryonic chicken growth. J Morphology 88: 
49-92.   
Harmsen J. 2007. Measuring bioavailability: From a scientific approach to standard 
methods. J Environ Qual 36: 1420-1428.  
78 
 
Hasegawa R, Futakuchi M, Mizoguchi Y, Yamaguchi T, Shirai T, Ito N and Lijinsky W. 
1998. Studies of initiation and promotion of carcinogenesis by N-nitroso compounds. 
Cancer Lett 123: 185-191.   
Haussmann HJ, Werringloer J. 1987. Mechanism and control of denitrosation of N-
nitrosodimethylamine. IARC Scientific Publications 84: 109-112.  
Hiramoto K, Ryuno Y, Kikugawa K. 2002. Decomposition of N-nitrosamines, and 
concomitant release of nitric oxide by Fenton reagent under physiological conditions. 
Mutation Res 520: 103-111.  
Iannaccone PM, Tsao TY, Stols L. 1982. Effects on mouse blastocysts of in vitro 
exposure to methylnitrosourea and 3- methylcholantherene. Cancer Res 42: 864-868.  
IARC Monographs- Classifications: 
http://monographs.iarc.fr/ENG/Classification/ClassificationsGroupOrder.pdf  
Inouye M, Murakami U. 1978. Teratogenic effect of N-methyl-N’-nitro-N-
nitrosoguanidine in mice. Teratology 18: 263-268. 
Jelinek R, Peterka M. 1985. Chick embryotoxicity screening test-130 substances tested. 
Indian Experimental Biol 23: 588-595.  
Kaur H, Halliwell B. 1994. Nitrotyrosine in serum and synovial fluid from rheumatoid 
patients. FEBS Letters 350: 9-12.  
Keefer LK, Anjo T, Wade D, Wang T, Yang CS. 1987. Concurrent generation of 
methylamine and nitrite during denitrosation of N-nitrosodimethylamine by rat liver 
microsomes. Cancer Res 47: 447-452. 
79 
 
Kilbourn RG, Belloni P. 1990. Endothelial cell production of nitrogen oxides in response 
to interferon gamma in combination with tumor necrosis factor, interleukin-1, or 
endotoxin. National Cancer Institute 82: 772-776.  
Kingdon EJ, Mani AR, Frost MT, Denton CP, Powis SH, Black CM, Moore KP. 2006.  
Low plasma protein nitrotyrosine levels distinguish primary Raynaud’s phenomenon 
from scleroderma. Ann Rheum Dis 65: 952–954.  
Koyama T, Handa J, Handa H, Matsumoto. 1970. Methylnitrosourea induced 
malformations of brain in SD-JCL rat. Arch Neurol 22: 342–347.  
Kruger NJ. 2002. The Bradford method for protein quantitation. In: Walker JM, editor. 
The protein protocols handbook. New Jersey: Human Press Inc. p 15-21. 
Kulshrestha P, Mckinstry KC, Fernandez BO, Feelisch M, Mitch WA. 2010. Application 
of an optimized total N-nitrosamine (TONO) assay to pools: Placing N-
nitrosodimethylamine determinations into perspective. Environ Sci Technol 44: 3369-
3375.  
Lacasana M, Grameix HV, Borja-Aburto VH, Munoz JB, Romieu I, Garduno CA, Garcia 
AM. 2006. Maternal and paternal occupational exposure to agricultural work and the risk 
of anencephaly. Occup Environ Med 63: 649-656.  
Laughon M, Meyer R, Bose C, Wall A, Otero E, Heerens A, Clark R. 2003. Rising birth 
prevalence of gastroschisis. J Perinatol 23: 291-293.  
Leaf CD, Wishnok JS, Tannenbaum SR. 1989. L-arginine is a precursor for nitrate 
biosynthesis in humans. Biochem Biophys Res Commun 8: 1032-1037. 
80 
 
Lee SJ, Shin JH, Sung NJ, Kim JG, Hotchkiss JH. 2003. Effect of cooking on the 
formation of N-nitrosodimethylamine in Korean dried seafood products. Food Addit 
Contam 20: 31-36 
Lee VM, Keefer LK, Archer MC.  1996.  An evaluation of the roles of metabolic 
denitrosation and α-hydroxylation in the hepatotoxicity of N-nitrosodimethylamine.  
Chem Res Toxicol  9: 1319-1324.   
Lie OV, Bennett GD, Rosenquist TH. The N-methyl-D-aspartate receptor in heart 
development: A gene knockdown model using siRNA. 2010. Reprod Toxicol 29: 32-41. 
Lijinsky W, Greenblatt M. 1972. Carcinogen dimethylnitrosamine produced in vivo from 
sodium nitrite and aminopyrene. Nature New Biol 236: 177-178.  
Lijinsky W, Taylor HW. 1977. Carcinogenesis tests of nitroso-methylpiperazine, 2,3,5,6,-
tetramethyldinitrosopiperazine, nitrosoisonipecotic acid and nitrosomethoxymethylamine 
in rats. Z Krebsforsch 89: 31-36.   
Lijinsky W,Conrad E, Van de Bogart R. 1972. Formation of carcinogenic nitrosamines 
by interaction of drugs with nitrite. In: N-nitroso compounds, Analysis and Formation, 
IARC Scientific Publication No 3: 130-133.  
Lijinsky W. 1999. N-nitroso compounds in the diet. Mutat Res-Gen Tox Env 443: 129-
138.   
Lijinsky W. Conrad E, Van de Bogart R. 1972. Carcinogenic nitrosamines formed by 
drug/nitrite interactions. Nature 239: 165-167.   
81 
 
Lijinsky W, Epstein SS. 1970. Nitrosamines as environmental carcinogens. Nature  225: 
21 – 23.    
Loeppky RN, Michejda CJ. 1994. N-Nitroso Compounds, Chemistry and Biochemistry. 
Washington, DC: ACS Symposium Series 553; American Chemical Society. p XI-XII. 
Lofberg B. 1985. Tissue specificity of N-nitrosomorpholine metabolism in Sprague 
dawley rats. Fd Chem Toxicol 23: 647-654.  
Madeleine RB, Van Straaten HM. 2005. Models of neural tube defects. Drug Discov 
Today Dis Models 2: 285-290.   
Maduagwu EN, Bassir O. 1979. Comparative embryotoxicity of dimethylnitrosamine in 
the chick embryo. J Agric Food Chem 27: 396-398.  
Magee PN, Barnes JM. 1967. Carcinogenic nitroso compounds. Adv Cancer Res 10: 163-
246.    
Manassaram DM, Backer LC, Moll DM. 2007. A review of nitrates in drinking water: 
maternal exposure and adverse reproductive and developmental outcomes. Environ 
Health Perspec 114: 320–327.  
Manson D, Cox PJ, Jarman M. 1978. Metabolism of N-nitrosomorpholine by the rat in 
vivo and by rat liver microsomes and its oxidation by the fenton system. Chem Biol 
Interact 20: 341-354.  
Matthew JK., Karina SC. 2007.  Windowing chicken eggs for developmental studies. 
Video Article. Journal of Visualized Experiments. 
http://www.jove.com/index/Details.stp?ID=306. 2007. 
82 
 
McKnight GM, Duncan CW, Leifert C, Golden MH. 1999. Dietary nitrate in man: friend 
or foe? Brit J Nutr 81: 349-358.  
Meisner LF, Roloff BD, Belluck DA. 1993. In vitro effects of N-nitrosoatrazine on 
chromosome breakage. Arch Environ Contam Toxicol 24: 108-112.  
Mergens WJ.1982. Efficacy of vitamin E to prevent nitrosamine formation. Ann NY 
Acad Sci 393: 61-69.   
Mine Y. 2007. Egg proteins and peptides in human health – chemistry, bioactivity and 
production. Curr Pharm Des 13: 875-884.  
Mirvish SS. 1986. Effects of vitamins C and E on N-nitroso compound formation, 
carcinogenesis and cancer. Cancer 58: 1842-1850.  
Mirvish SS, Gannett P, Babcook D, Williamson D, Chen S and Weisenburger D. 1991. 
N-nitrosoatrazine: Synthesis, kinetics of formation, and Nuclear Magnetic Resonance 
spectra and other properties. J. Agric Fd Chem 39: 1205-1210. 
Mirvish SS, Issenberg P, Sams JP. 1981. N-nitrosomorpholine synthesis in rodents 
exposed to nitrogen dioxide and morpholine. In: Scanlan RA and  Tannenbaum S, 
editors. N-nitroso Compounds, ACS Symposium Series 174. Washington, D. C.: 
American Chemical Society. p 181-191.  
Mirvish SS. 1970. Kinetics of dimethylamine nitrosation in relation to nitrosamine 
carcinogenesis. J Natl Cancer Inst 44: 633-639.  
83 
 
Mirvish SS. 1972. Kinetics of N-nitrosation reactions in relation to tumorigenesis 
experiments with nitrite plus amines or ureas. N-nitroso Compounds Anal Form Proc 
Work Conf 104-8. 
Mirvish SS. 1975. Formation of N-nitroso compounds: Chemistry, kinetics, and in vivo 
occurrence. Toxicol Appl Pharmacol 31: 325-51.    
Mirvish SS. 1977. N-nitroso compounds: their chemical and in vivo formation and 
possible importance as environmental carcinogens. J Toxicol Environ Health 2: 1267-77.  
Mirvish SS. 1983. The etiology of gastric cancer: Intragastric nitrosamide formation and 
other theories. J Natl Cancer Inst 71: 629-647. 
Mirvish SS. 1995. Role of N-nitroso compounds and N-nitrosation in etiology of gastric, 
esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known 
exposures to NOC. Cancer Lett 93: 17-48.   
Mirvish SS. 2008. Methods for the determination of N-nitroso compounds in food and 
biological fluids. Compr Analyt Chem 51: 653-684. 
Mitch WA, Sharp JO, Trussel RR, Valentine RL, Alvarez-Cohen L, Sedlak DL. 2003. N-
nitrosodimethylamine as a drinking water contaminant: A review. Environ Eng Sci 5: 
189-404 
Mohiuddin I, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. 2006. Nitrotyrosine and 
chlorotyrosine: Clinical significance and biological functions in the vascular system. J 
Surg Res 133: 143-149.  
84 
 
Moncada S, Palmer RMJ, Higgs EA. 1991. Nitric oxide: Physiology, pathophysiology, 
and pharmacology. Pharmacol Rev 43: 109-42.  
Mulligan MS, Hevel JM, Marletta MA and Ward PA.1991. Tissue injury caused by 
deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 88: 
6338–6342. 
Nakazawa H, Fukuyama N, Takizawa S, Tsuji C, Yoshitake M, Ishida H. 2000. 
Nitrotyrosine formation and its role in various pathological conditions. Free Rad Res 33: 
771-784.  
Oomen AG, Hack A, Minekus M, Zeijdner E, Cornelis C, Schoeters G, Verstraete W, 
Wiele TVD, Wragg J, Rompelberg CJM, Sips AJA, Wijnen JHV. 2002. Comparison of 
five in vitro digestion models to study the bio-accessibility of soil contaminants. Environ 
Sci Technol 36: 3326-3334.  
Pacher P, Beckman JS, Liaudet L. 2007. Nitric oxide and peroxynitrite in health and 
disease. Physiol Rev 87: 315-424.  
Padhye L, Wang P, Karanfil T, Huang CH. 2010. Unexpected role of activated carbon in 
promoting transformation of secondary amines to N-nitrosamines. Environ Sci Technol 
44: 4161-4168.  
Palmer KJ. 1944. The structure of an egg albumin–detergent complex. J Phys Chem 48: 
12–21.  
Pegg AE. 1980. Metabolism of N-nitrosodimethylamine. In: Montesano R, Bartsch H, 
and Tomatis L, editors. Molecular and Cellular Aspects of Carcinogen Screening Tests, 
85 
 
IARC Scientific Publication.  Lyon, France: International Agency for Research on 
Cancer. p 3-22. 
Preussmann R, Stewart BW. 1984. N-nitroso carcinogens. In: Searle CE, editor. 
Chemical carcinogens. Washington DC:  ACS Monographs 182- 2,-American Chemical 
Society. p 643-868. 
Pryor WA , Lightsey JW. 1981. Mechanisms of nitrogen dioxide reactions: Initiation of 
lipid peroxidation and the production of nitrous acid. Science 214: 435–437.  
Rosenberg I, Gross J, Spears T, Rahn P. 1980. Analysis of nitrosamines in cosmetic raw 
materials and finished products by high pressure liquid chromatography. J Soc Cosmet 
Chem 31: 237-252.   
Rosenquist TH, Bennett GD, Brauer PR, Stewart ML, Chaudoin TR, Finnell RH. 2007. 
Microarray analysis of homocysteine responsive genes in cardiac neural crest cell in 
vitro. Dev Dyn 236: 1044-1054. 
Rosenquist TH, Chaudoin T, Finnell RH, Bennett GD. 2010. High affinity folate receptor 
in cardiac neural crest migration: A gene knockdown model using siRNA. Dev Dyn 239: 
1136-1144.  
Rosenquist TH, Finnell RH. 2001. Genes, folate and homocysteine in embryonic 
development. Proc Nutr Soc 60: 53-61.  
Schafer AI, Mitch W, Walewijk S, Munoz A, Teuten E, Reinhard M. 2010. 
Micropollutants in water recycling: A case study of N-nitrosodimethylamine exposure 
from water versus food. Sustainability Science and Engineering 2: 203-228.  
86 
 
Sen NP, Baddoo PA. 1986. Origin of N-nitrosomorpholine contamination in margarine. J 
Food Sci 51: 216-217.  
Sen NP, Baddoo PA. 1987. An investigation on the possible presence of morpholine and 
N-nitrosomorpholine in wax coated apples. J Food Saf  9: 183-191.  
Sen NP, Kushwaha SC, Seaman SW, Clarkson SG. 1985. Nitrosamines in baby bottle 
nipples and pacifiers: Occurrence, migration and effect of infant formulas and fruit juices 
on in vitro formation of nitrosamines under simulated gastric conditions. J Agric Food 
Chem 33: 428-433.  
Spalding RF, Exner ME, Snow DD, Cassada DA, Burbach ME, Monson SJ. 2003. 
Herbicides in ground water beneath Nebraska’s Management Systems Evaluation Area. J 
Environ Qual 32: 92-99.  
Spiegelhalder B, Eisenbrand G, Preussmann R. 1976. Influence of dietary nitrate on 
nitrite content of human saliva: Possible relevance to in vivo formation of N-nitroso 
compounds. Food Cosmet Toxicol 14: 545–548.  
Spiegelhalder B, Preussmann R. 1983. Occupational nitrosamine exposure 1. Rubber and 
tyre industry. Carcinogenesis 4: 1147-1152.  
Stahlmann R, Bluth U, Wiessler M, Neubert D. 1983. Interference of acetoxyalkyl-
nitrosamines with limb bud differentiation in organ culture. Arch Toxicol 54: 109-129.  
Stamler JS, Singel DJ, Loscalzo J. 1992. Biochemistry of nitric oxide and its redox 
activated forms. Science 258: 1898-1902.  
87 
 
Straif K, Weiland SK, Bungers M, Holthenrich D, Taeger D, Yi S, Keil U. 2000. 
Exposure to high concentrations of nitrosamines and cancer mortality among a cohort of 
rubber workers. Occup Environ Med 57: 180-187.  
Takeuchi IK. 1984. Teratogenic effects of methylnitrosourea on pregnant mice before 
implantation. Cell Mol Life Sci 40: 879-881. 
Takizawa S, Fukuyama N, Hirabayashi H, Nakazawa H, Shinohara Y. 1999. Dynamics of 
nitrotyrosine formation and decay in rat brain during focal ischemia reperfusion. J Cereb 
Blood Flow Metab 19: 667-672.  
Tarpey MM, Wink DA, Grisham MB. 2004. Methods for detection of reactive 
metabolites of oxygen and nitrogen: In vitro and in vivo considerations. Am J Physiol 
Regul Integr Comp Physiol 286: R431-R444.  
Tenovuo.1986. The biochemistry of nitrates, nitrites, nitrosamines and other potential 
carcinogens in human saliva. Oral Pathol 15: 303-307.  
Ternes W. 2001. Egg proteins. In: Sikorski ZE, editor. Chemical and functional 
properties of food proteins. Pennsylvania: Technomic Pub Co Inc. p 335-371. 
Tiboni GM, Clementini E. 2004. Teratological consequences of nitric oxide synthesis 
inhibition. Curr Pharm Des 10: 2759-2767.  
Tong M, Longato L, Monte SM. 2010. Early limited nitrosamine exposures exacerbate 
high fat diet mediated type 2 diabetes and neurodegeneration. BMC Endocr Disord 10: 1-
16. 
88 
 
Torfs CP, Lam PK, Schaffer DM, Brand RJ. 1998. Association between mothers nutrient 
intake and their offspring’s risk of gastroschisis. Teratology 58: 241-250.  
Trapp MEB, Lanoue L, Keen CL, Rucker RB, Adams JYU. 2006. Abnormal 
development and increased 3-nitrotyrosine in copper deficient mouse embryos. Free 
Radic Biol Med 40: 35-44.  
Tricker AR, Preussmann R. 1991.Carcinogenic N-nitrosamines in the diet: Occurrence, 
formation, mechanisms and carcinogenic potential. Mutat Res 259: 277-289.   
Tricker AR, Spiegelhalder B, Preussmann R. 1989. Environmental exposure to preformed 
nitroso compounds. Cancer Surv 8: 251-72. 
Tricker AR. 1997. N-nitroso compounds and man: Sources of exposure, endogenous 
formation and occurrence in body fluids. Eur J Cancer Prev 6: 226–268.  
Vocht F de, Burstyn I, Straif K, Vermeulen R, Jakobsson K, Nichols L, Peplonska B, 
Taeger D, Kromhout H. 2007. Occupational exposure to NDMA and NMOR in the 
European rubber industry. J Environ Monit 9: 253-259. 
Vu LT, Nobuhara KK, Laurent C, Shaw GM. 2008. Increasing prevalence of 
gastroschisis: Population based study in California. J Pediatr 152: 807-811.  
Walker R. 1990. Nitrates, nitrites and N-nitrosocompounds: A review of the occurrence 
in food and diet and the toxicological implications. Food Addit Contam 7: 717-768.   
Walse SS, Mitch WA. 2008. Nitrosamine carcinogens also swim in chlorinated pools. 
Environ Sci Technol 42: 1032-1037.  
89 
 
Ward MH, deKok TM, Levallois P, Brender J, Gulis G, Nolan BT, VanDerslice J. 2005. 
Workgroup report: Drinking water nitrate and health- Recent findings and research needs. 
Environ Health Perspect 113: 1607–1614. 
Weisenburger DD, Joshi SS, Hickman TI, Babcook DM, Walker BA, Mirvish SS. 1988. 
N-Nitroso-atrazine (NNAT): Synthesis, chemical properties, acute toxicity, and 
mutagenicity. In: American Association for Cancer Research. Proceedings of the 
American Association for Cancer Research; 1987 May 20-23; Atlanta (GA). 
Philadelphia, PA: American Association for Cancer Research, 1987:103. 
WHO: NDMA: http://www.inchem.org/documents/cicads/cicads/cicad38.htm 
WHO: Nitrates, Nitrites and N-nitroso compounds 
http://www.inchem.org/documents/ehc/ehc/ehc005.htm 
WHO: N-nitrosomorpholine 
http://www.inchem.org/documents/iarc/vol17/nitrosomorpholine.html 
WHO:Morpholine- 
http://www.inchem.org/documents/ehc/ehc/ehc179.htm#SectionNumber:1.3 
Williams DLH. 2004. Nitrosation reactions and the chemistry of nitric oxide. San Diego: 
Elsevier Inc. p 268.  
Wolfe NL, Zebb RG, Gordon JA, Fincher RC. 1976. N-Nitrosamine formation from 
atrazine. Bull Environ Contam Toxicol 15: 342-341. 
90 
 
Xu GP, Reed PI. 1993. N-Nitroso compounds in fresh gastric juice and their relation to 
intragastric pH and nitrite employing an improved analytical method. Carcinogenesis 14: 
2547-2551.  
Yurchenko S, Molder U. 2006. Volatile N-nitrosamines in various fish products. Food 
Chem 96: 325-333.  
  
91 
 
APPENDIX A: STABILITY AND TRANSFER OF SELECTED NITROSAMINES 
Average weight of egg fractions 
Egg Fraction Average weight 
(g) 
Egg white 30.0 
Membrane 8.0 
Yolk 12.0 
Whole egg 
(without shell) 
50.0 
 
Percent recovery of nitrosamines from each fraction of egg 
Egg Fraction NDMA  
(%) 
NMOR  
(%) 
NNAT 
(%) 
Egg White 100 100 49 
Membrane 80 88 63 
Yolk 60 99 37 
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APPENDIX B: TERATOGENIC POTENTIAL OF SELECTED NITROSAMINES 
NDMA 
Number of eggs treated with NDMA 
Dose (µg) No. treated No. unfertilized No. dead No. malformed 
Controls 25 0 1 1 
12.5 10 2 0 0 
25.0 10 1 0 1 
50.0 20 1 2 5 
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SAS output  
                                          Case-Control Study of Malformation               
                                                      The FREQ Procedure 
 
Statistics for Table of Treatment by Outcome 
Statistic                                    DF       Value      Prob 
Chi-Square                                 6      6.6753    0.3519 
Chi square test shows that no statistically significant relationship exists between 
treatment with NDMA and subsequent adverse effects (i.e. mortality and deformity) 
in chicken embryos. 
 
 
 
 
 
 
 
 
94 
 
Case-Control Study of Malformation 
 
The FREQ Procedure 
 
Statistics for Table of trt by Outcome 
 
Estimates of the Relative Risk (Row1/Row2) 
 
    Type of Study                   Value        95% Confidence Limits 
Case-Control (Odds Ratio)    0.2576        0.0290        2.2874 
Cohort (Col1 Risk)                0.2899        0.0372        2.2604 
Cohort (Col2 Risk)                1.1253        0.9622        1.3162 (>1) 
 
Analysis of relative risk indicates that the risk of mortality or malformations in 
chicken embryos from exposure to NDMA is very low (95% CI) 
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NMOR 
Number of eggs treated with NMOR 
Dose 
(µg) 
No. 
treated 
No. 
unfertilized 
No. 
dead 
No. 
malformed 
Controls 35 3 1 1 
25.0 
250.0 
1250.0 
2500.0 
5000.0 
7500.0 
15 
15 
10 
30 
15 
15 
2 
2 
 
1 
 
4 
 
0 
 
1 
0 
   1 
 
   0 
 
   10 
 
   5 
 
   11 
3 
0 
 
1 
 
8 
 
4 
 
2 
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SAS output 
Case-Control Study of Malformation 
The FREQ Procedure 
 
Table of Treatment by Outcome 
 
                                         Treatment     Outcome 
 
 
 
Statistics for Table of Treatment by Outcome 
 
Statistic                    DF       Value      Prob 
Chi-Square               12     54.5979    <.0001 
Chi square test shows that NMOR has a statistically significant impact on 
development of chicken embryos (malformations and death). 
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Statistics for Table of Treatment by Outcome 
 
Statistic                         DF       Value      Prob 
Chi-Square                     6     15.0753    0.0197 
Chi square test shows that there is a statistically significant relationship between 
exposure to NMOR and subsequent malformations in chicken embryos.  
Case-Control Study of Malformation           
The FREQ Procedure 
 
Statistics for Table of trt by Outcome 
 
Estimates of the Relative Risk (Row1/Row2) 
 
         Type of Study                   Value       95% Confidence Limits 
Case-Control (Odds Ratio)      0.1129        0.0144        0.8850 
Cohort (Col1 Risk)                  0.1406        0.0196        1.0100 
Cohort (Col2 Risk)                  1.2455        1.0915        1.4213 
Analysis of relative risk indicates that risk of malformations in chicken embryos 
from exposure to NMOR is significantly high. 
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Statistics for Table of Treatment by Outcome 
 
 Statistic                     DF       Value      Prob 
 Chi-Square                 6     44.3219    <.0001 
Results from chi square test show that there is a statistically significant relationship 
between exposure to NMOR and subsequent mortality in chicken embryos. 
Case-Control Study of Malformation               
The FREQ Procedure 
 
Statistics for Table of trt by Outcome 
 
Estimates of the Relative Risk (Row1/Row2) 
 
Type of Study                          Value       95% Confidence Limits 
Case-Control (Odds Ratio)      0.0753        0.0098        0.5799 
Cohort (Col1 Risk)                  0.1042        0.0148        0.7356 
Cohort (Col2 Risk)                1.3839        1.1925        1.6061 
Analysis of relative risk indicates that risk of death in chicken embryos from 
exposure to NMOR is significantly high. 
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NNAT 
Number of eggs treated with NNAT 
Dose 
(µg) 
No. 
treated 
No. 
unfertilized 
No. 
dead 
No. 
malformed 
Controls 75 2  0         0 
0.06 
0.12 
0.23 
0.46 
0.91 
1.82 
3.63 
5.50 
7.25 
14.50 
30 
25 
25 
40 
25 
30 
40 
15 
25 
25 
4 
2 
 
0 
 
2                                    
 
2                
 
3 
 
0 
 
0 
 
2 
 
2 
 3 
    3 
 
    0 
 
    4 
 
    4 
 
    2 
 
    3 
 
    0 
 
    1 
 
    0  
        3 
        6 
 
        6 
 
11 
 
        9 
 
        3 
 
        16 
 
        6 
 
        7 
 
        7 
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SAS output 
 
Case-Control Study of Malformation 
 
The FREQ Procedure 
 
Statistics for Table of Treatment by Outcome 
 
Statistic                         DF       Value      Prob 
Chi-Square                    20     50.2383    0.0002                                                                
Chi square test shows that NNAT has a statistically significant impact on 
development of chicken embryos (malformations and death).  
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Case-Control Study of Malformation 
 
The FREQ Procedure 
 
Statistics for Table of Treatment by Outcome 
 
Statistic                         DF       Value      Prob 
Chi-Square                    10     32.0366    0.0004 
Chi square test shows that there is a statistically significant relationship between 
exposure to NNAT and subsequent malformations in chicken embryos.  
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Case-Control Study of Malformation 
 
The FREQ Procedure 
 
Statistics for Table of trt by Outcome 
 
Estimates of the Relative Risk (Row1/Row2) 
 
Type of Study                       Value       95% Confidence Limits 
Cohort (Col2 Risk)             1.3109        1.2323        1.3946 
Analysis of relative risk indicates that risk of malformations in chicken embryos 
from exposure to NNAT is significantly high. 
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Case-Control Study of Malformation 
 
The FREQ Procedure 
 
Statistics for Table of Treatment by Outcome 
 
Statistic                       DF       Value      Prob 
Chi-Square                    10     20.1202    0.0281 
Chi square test shows that there is a statistically significant relationship between 
exposure to NNAT and subsequent mortality in chicken embryos. 
Case-Control Study of Malformation               
 
The FREQ Procedure 
 
Statistics for Table of trt by Outcome 
 
Estimates of the Relative Risk (Row1/Row2) 
 
Type of Study                     Value       95% Confidence Limits 
Cohort (Col2 Risk)             1.0840        1.0464        1.1231 
Analysis of relative risk indicates that risk of death in chicken embryos from 
exposure to NNAT is significantly high. 
 
 
  
104 
 
APPENDIX C:  IMPACT OF NNAT ON NITROTYROSINE 
CONCENTRATIONS IN CHICKEN EMBRYOS 
Nitrotyrosine concentrations in controls and embryos treated with different doses of 
NNAT 
No.  Treatment  Nitrotyrosine 
nmol/µg Protein 
     
1 Control 1 824.0 
2 Control 2 787.6 
3 Control 3 14292.4 
4 Control 4 699.5 
5 Control 5 474.9 
6 Control 6 450.8 
7 Control 7 438.9 
8 Control 8 318.7 
9 NNAT 0.06 µg  Normal (1) 281.0 
10 NNAT 0.06 µg  Normal (2) 293.2 
11 NNAT 0.06 µg  Normal (3) 256.9 
12 NNAT 0.06 µg  Normal (4) 402.7 
13 NNAT 0.06 µg  Malformed (1) 407.6 
14 NNAT 0.06 µg  Malformed (2) 384.7 
15 NNAT 0.06 µg  Malformed (3) 327.8 
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16 NNAT 0.06 µg  Malformed (4) 410.0 
17 NNAT 0.23 µg Normal (1) 501.2 
18 NNAT 0.23 µg Normal (2) 959.9 
19 NNAT 0.23 µg Normal (3) 568.7 
20 NNAT 0.23 µg Normal (4) 548.6 
21 NNAT 0.23 µg Malformed (1) 579.5 
22 NNAT 0.23 µg Malformed (2) 501.2 
23 NNAT 0.23 µg Malformed (3) 617.5 
24 NNAT 0.23 µg Malformed (4) 737.8 
25 NNAT 0.46 µg Normal (1) 311.8 
26 NNAT 0.46 µg Normal (2) 293.1 
27 NNAT 0.46 µg Normal (3) 182.1 
28 NNAT 0.46 µg Normal (4) 195.7 
29 NNAT 0.46 µg Normal (5) 358.2 
30 NNAT 0.46 µg Normal (6) 388.7 
31 NNAT 0.46 µg Normal (7) 287.3 
32 NNAT 0.46 µg Normal (8) 280.1 
33 NNAT 0.46 µg Malformed (1) 676.0 
34 NNAT 0.46 µg Malformed (2) 1697.0 
35 NNAT 0.46 µg Malformed (3) 1099.0 
36 NNAT 0.46 µg Malformed (4) 1105.1 
37 NNAT 0.46 µg Malformed (5) 380.8 
38 NNAT 0.46 µg Malformed (6) 326.5 
106 
 
39 NNAT 0.46 µg Malformed (7) 372.8 
40 NNAT 0.46 µg Malformed (8) 426.4 
41 NNAT 0.91 µg Normal (1) 338.9 
42 NNAT 0.91 µg Normal (2) 257.9 
43 NNAT 0.91 µg Normal (3) 241.4 
44 NNAT 0.91 µg Normal (4) 886.7 
45 NNAT 0.91 µg Malformed (1) 1146.4 
46 NNAT 0.91 µg Malformed (2) 864.7 
47 NNAT 0.91 µg Malformed (3) 758.4 
48 NNAT 0.91 µg Malformed (4) 861.3 
49 NNAT 3.63 µg Normal (1) 223.6 
50 NNAT 3.63 µg Normal (2) 227.7 
51 NNAT 3.63 µg Normal (3) 550.7 
52 NNAT 3.63 µg Normal (4) 193.2 
53 NNAT 3.63 µg Malformed (1) 372.9 
54 NNAT 3.63 µg Malformed (2) 306.9 
55 NNAT 3.63 µg Malformed (3) 257.0 
56 NNAT 3.63 µg Malformed (4) 466.7 
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SAS output  
Paired t-test to compare nitrotyrosine concentrations in NNAT treated malformed 
and NNAT treated normal embryos 
Dose: 0.06 µg: 
The TTEST Procedure 
Statistics                            
Difference                    N    Std Err 
Normal - Malformed    4    0.0755 
T-Tests 
Difference                       DF    t Value    Pr > |t| 
Normal - Malformed          3      -3.14      0.0515- Difference is statistically significant 
Dose: 0.23 µg: 
The TTEST Procedure 
Statistics                             
Difference                    N           Std Err 
Normal - Malformed    3            0.1 
 
T-Tests 
Difference                        DF    t Value    Pr > |t| 
Normal - Malformed          2      -3.32      0.08- Difference is not statistically significant 
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Dose: 0.46 µg: 
The TTEST Procedure 
Statistics                             
Difference                    N           Std Err 
Normal - Malformed    8            0.59 
T-Tests 
Difference                        DF    t Value    Pr > |t| 
Normal - Malformed          7      -2.54      0.0388- Difference is statistically significant 
Dose: 0.91 µg: 
The TTEST Procedure 
Statistics                       
Difference                    N           Std Err 
Normal - Malformed    3            0.27 
T-Tests 
Difference                        DF    t Value    Pr > |t| 
Normal - Malformed          2      -7.49      0.0173- Difference is statistically significant 
Dose: 3.63 µg: 
The TTEST Procedure 
Statistics                       
Difference                    N           Std Err 
Normal - Malformed    4            0.11 
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T-Tests 
Difference                        DF    t Value    Pr > |t| 
Normal - Malformed          3      -5.49      0.0119- Difference is statistically significant 
One way analysis of variance (ANOVA) to compare nitrotyrosine concentrations in 
NNAT treated and control embryos 
The SAS System 
The Mixed Procedure 
 
Number of Observations Read              55 
Number of Observations Used              55 
Number of Observations Not Used         0 
Differences of Least Squares Means 
Effect         Treatment                                   Treatment                Adj P 
Treatment   NNAT 0.06 Normal                  Control                    0.4877 
Treatment   NNAT 0.06 Malformed            Control                    0.8318 
Treatment   NNAT 0.23 Malformed            Control                    1.0000 
Treatment   NNAT 0.23 Normal                  Control                    1.0000 
Treatment   NNAT 0.46 Malformed            Control                    0.6430 
Treatment   NNAT 0.46 Normal                  Control                    0.1917 
Treatment   NNAT 0.91 Malformed            Control                    0.2082 
Treatment   NNAT 0.91 Normal                  Control                    0.9655 
Treatment   NNAT 3.63 Malformed            Control                    0.6921 
110 
 
Treatment   NNAT 3.63 Normal                  Control                    0.2468 
 
The adjusted P values indicate that nitrotyrosine concentrations were not 
statistically significantly different between NNAT treated (malformed and normal) 
five day old embryos and the controls.  
 
One way analysis of variance (ANOVA) to compare nitrotyrosine concentrations in 
embryos treated with various doses of NNAT 
The Mixed Procedure 
Differences of Least Squares Means 
Effect            Trt                               Trt                           Pr > |t 
 
Trt             NNAT 0.06               NNAT 0.23                  0.0829 
Trt             NNAT 0.06               NNAT 0.46                  0.1034 
Trt             NNAT 0.06               NNAT 0.91                  0.0125 
Trt             NNAT 0.06               NNAT 3.63                  0.6283 
Trt             NNAT 0.23               NNAT 0.46                  0.6562 
Trt             NNAT 0.23               NNAT 0.91                  0.4628 
Trt             NNAT 0.23               NNAT 3.63                  0.0351 
Trt             NNAT 0.46               NNAT 0.91                  0.1807 
Trt             NNAT 0.46               NNAT 3.63                  0.0390 
Trt             NNAT 0.91               NNAT 3.63                  0.0047 
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The p-values indicate that there was a significant difference in the nitrotyrosine 
concentrations of embryos treated with 0.06 µg NNAT and those treated with NNAT 
dose 0.91 µg. Similarly, there was a significant difference in the nitrotyrosine 
concentrations of embryos treated with 0.23 µg NNAT and those treated with the 
highest NNAT dose of 3.63 µg. There was also a significant difference in the 
nitrotyrosine concentrations of embryos treated with 0.46 µg and 0.91 µg NNAT and 
those treated with 3.63 µg NNAT. 
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One way analysis of variance (ANOVA) to compare nitrotyrosine concentrations in 
controls with embryos exposed to NNAT that were normal  
The SAS System 
The Mixed Procedure 
Differences of Least Squares Means 
 
Effect             Trt                     Trt                   Adj P 
Trt       NNAT 0.06              Control               0.0586 
Trt       NNAT 0.23              Control               0.9989 
Trt       NNAT 0.46              Control               0.0089 
Trt       NNAT 0.91              Control               0.5314  
Trt       NNAT 3.63              Control               0.0145 
 
The p-values indicate that the nitrotyrosine concentrations in normal – appearing 
embryos treated with 0.46µg and 3.63 µg NNAT were significantly different from 
nitrotyrosine in control embryos. 
 
 
